August-2012

First

Last

TITLE PUBLISHED PRICE

Organic Light Emitting Diodes (OLEDs): Technologies and Global Markets By BCC Research Global shipments of OLEDs totaled $3.2 billion in 2011 and $4.9 billion in 2012. Total OLED shipment value is expected to reach $20.3 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 32.6%.Display...	August 2012	$5450
2012 Market Research Report on China Linear Guideway Industry By QYResearch Group 2012 Market Research Report on China Linear Guideway Industry was professional and depth research report on China Linear Guideway industry. The report firstly introduced Linear Guideway basic information included Linear Guideway definition classif...	August 2012	$2000
2012 Market Research Report on China Ball Screw Industry By QYResearch Group 2012 Market Research Report on China Ball Screw Industry was professional and depth research report on China Ball Screw industry. The report firstly introduced Ball Screw basic information included Ball Screw definition classification application ...	August 2012	$2000
2012 Market Research Report on China Synthesis Polypeptide Drug Industry By QYResearch Group 2012 Market Research Report on China Synthesis Polypeptide Drug Industry was professional and depth research report on China Synthesis Polypeptide Drug industry. The report firstly introduced Synthesis Polypeptide Drug basic information included S...	August 2012	$2000
World Agricultural Pesticides to 2016 By Freedonia Group This study analyzes the world agricultural pesticide industry. It presents historical demand data for the years 2001, 2006 and 2011, and forecasts for 2016 and 2021 by agricultural pesticide product (e.g., herbicides, insecticides, fungicides), ma...	August 2012	$6200
Global and China Automotive Audio and Navigation Industry Report, 2011-2012 By Research In China Global and China Automotive Audio and Navigation Industry Report, 2011-2012 covers the followings:Brief Introduction of Automotive AudioBrief Introduction of TelematicsGlobal Automotive Market and Ind...	August 2012	$2600
Future Horizons in the Global Sexually-Transmitted Disease Market By Venture Planning Group About this Report This report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan.  Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gon...	August 2012	$8500
Future Horizons in the Global Enteric Disease Market By Venture Planning Group About this ReportThis report presents detailed analysis of the Enteric Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Campylobacter, Cryptospo...	August 2012	$9800
Future Horizons in the Global Respiratory Disease Market By Venture Planning Group About this ReportThis report presents detailed analysis of the Respiratory Disease market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza...	August 2012	$9200
2012 Deep Research Report on Global and China Aramid Fiber Industry By QYResearch Group 2012 Deep Research Report on Global and China Aramid Fiber Industry was a professional and depth research report on Global and China Aramid Fiber Industry. Firstly the report describes the background knowledge of Aramid Fiber, including Concepts C...	August 2012	$2200
Application Server: Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 By WinterGreen Research WinterGreen Research announces that it has published a new study Mission Critical J2EE Application Server: Market Shares, Strategy, and Forecasts, Worldwide, 2012 to 2018. The 2012 study has 686 pages, 297 tables and figures. Worldwide Application...	August 2012	$3700
Changing Consumer Attitudes and Future Outlook for the Budget Hotel Industry in BRIC By BRICdata The report provides market analysis, information and insights, including:In-depth analysis of the budget hotel industry in the four BRIC countries: Brazil, Russia, India and ChinaA comprehensive understanding of country-spec...	August 2012	$2950
Unconventional Natural Gas Extraction: Technologies and Global Markets By BCC Research The global market for unconventional natural gas extraction technologies was valued at nearly $61.2 billion in 2010 and nearly $61.6 billion in 2011. The market should reach $91.3 billion in 2016 after increasing at a five-year compound annua...	August 2012	$5450
Production and Market of Ethanolamine in China By CCM International In the past years, China's ethanolamine industry witnessed brilliant achievement, both in production and consumption. Now, China is the second largest producer and consumer of ethanolamine in the world, only next to the US.Since 2006, C...	August 2012	$6500
7TM Pharma A/S – Product Pipeline Review – 2012 By Global Markets Direct 7TM Pharma A/S – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “7TM Pharma A/S - Product Pipeline Review - 2012” provides data on the 7TM Pharma A/S’s research and development focus. The report includes	August 2012	$1500
Adamis Pharmaceuticals Corporation – Product Pipeline Review – 2012 By Global Markets Direct Adamis Pharmaceuticals Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Adamis Pharmaceuticals Corporation - Product Pipeline Review - 2012” provides data on the Adamis Pharmaceuticals Corpor	August 2012	$1500
AVEO Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct AVEO Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “AVEO Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the AVEO Pharmaceuticals, Inc.’s research and dev	August 2012	$1500
BioSante Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct BioSante Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “BioSante Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the BioSante Pharmaceuticals, Inc.’s rese	August 2012	$1500
Biotie Therapies Corp. – Product Pipeline Review – 2012 By Global Markets Direct Biotie Therapies Corp. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biotie Therapies Corp. - Product Pipeline Review - 2012” provides data on the Biotie Therapies Corp.’s research and development foc	August 2012	$1500
Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012 By Global Markets Direct Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Can-Fite BioPharma Ltd. - Product Pipeline Review - 2012” provides data on the Can-Fite BioPharma Ltd.’s research and development	August 2012	$1500
Celtic Biotech, Ltd. – Product Pipeline Review – 2012 By Global Markets Direct Celtic Biotech, Ltd. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Celtic Biotech, Ltd. - Product Pipeline Review - 2012” provides data on the Celtic Biotech, Ltd.’s research and development focus. Th	August 2012	$1500
Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012 By Global Markets Direct Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Cyclacel Pharmaceuticals Inc. - Product Pipeline Review - 2012” provides data on the Cyclacel Pharmaceuticals Inc.’s researc	August 2012	$1500
Endocyte, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Endocyte, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Endocyte, Inc. - Product Pipeline Review - 2012” provides data on the Endocyte, Inc.’s research and development focus. The report includes	August 2012	$1500
Flamel Technologies S.A. – Product Pipeline Review – 2012 By Global Markets Direct Flamel Technologies S.A. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Flamel Technologies S.A. - Product Pipeline Review - 2012” provides data on the Flamel Technologies S.A.’s research and developme	August 2012	$1500
Genta Incorporated – Product Pipeline Review – 2012 By Global Markets Direct Genta Incorporated – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Genta Incorporated - Product Pipeline Review - 2012” provides data on the Genta Incorporated’s research and development focus. The repo	August 2012	$1500
Geron Corporation – Product Pipeline Review – 2012 By Global Markets Direct Geron Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Geron Corporation - Product Pipeline Review - 2012” provides data on the Geron Corporation’s research and development focus. The report	August 2012	$1500
Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012 By Global Markets Direct Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Glenmark Pharmaceuticals Ltd. - Product Pipeline Review - 2012” provides data on the Glenmark Pharmaceuticals Ltd.’s researc	August 2012	$1500
iBio, Inc. – Product Pipeline Review – 2012 By Global Markets Direct iBio, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “iBio, Inc. - Product Pipeline Review - 2012” provides data on the iBio, Inc.’s research and development focus. The report includes information	August 2012	$1500
ImmunoGen, Inc. – Product Pipeline Review – 2012 By Global Markets Direct ImmunoGen, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “ImmunoGen, Inc. - Product Pipeline Review - 2012” provides data on the ImmunoGen, Inc.’s research and development focus. The report includ	August 2012	$1500
IMMUNOMEDICS, INC – Product Pipeline Review – 2012 By Global Markets Direct IMMUNOMEDICS, INC – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “IMMUNOMEDICS, INC - Product Pipeline Review - 2012” provides data on the IMMUNOMEDICS, INC’s research and development focus. The report	August 2012	$1500
Inovio Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Inovio Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Inovio Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Inovio Pharmaceuticals, Inc.’s research a	August 2012	$1500
Ipsen Inc. – Product Pipeline Review – 2012 By Global Markets Direct Ipsen Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Ipsen Inc. - Product Pipeline Review - 2012” provides data on the Ipsen Inc.’s research and development focus. The report includes information	August 2012	$1500
MerLion Pharmaceuticals Pte Ltd – Product Pipeline Review – 2012 By Global Markets Direct MerLion Pharmaceuticals Pte Ltd – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “MerLion Pharmaceuticals Pte Ltd - Product Pipeline Review - 2012” provides data on the MerLion Pharmaceuticals Pte Ltd’s r	August 2012	$1500
MethylGene Inc – Product Pipeline Review – 2012 By Global Markets Direct MethylGene Inc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “MethylGene Inc - Product Pipeline Review - 2012” provides data on the MethylGene Inc’s research and development focus. The report includes	August 2012	$1500
MOLOGEN AG – Product Pipeline Review – 2012 By Global Markets Direct MOLOGEN AG – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “MOLOGEN AG - Product Pipeline Review - 2012” provides data on the MOLOGEN AG’s research and development focus. The report includes information	August 2012	$1500
MorphoSys AG – Product Pipeline Review – 2012 By Global Markets Direct MorphoSys AG – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “MorphoSys AG - Product Pipeline Review - 2012” provides data on the MorphoSys AG’s research and development focus. The report includes inform	August 2012	$1500
Oncogenex Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Oncogenex Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Oncogenex Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Oncogenex Pharmaceuticals, Inc.’s r	August 2012	$1500
Onyx Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Onyx Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Onyx Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Onyx Pharmaceuticals, Inc.’s research and dev	August 2012	$1500
Phytopharm Plc – Product Pipeline Review – 2012 By Global Markets Direct Phytopharm Plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Phytopharm Plc - Product Pipeline Review - 2012” provides data on the Phytopharm Plc’s research and development focus. The report includes	August 2012	$1500
PolyMedix, Inc. – Product Pipeline Review – 2012 By Global Markets Direct PolyMedix, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “PolyMedix, Inc. - Product Pipeline Review - 2012” provides data on the PolyMedix, Inc.’s research and development focus. The report includ	August 2012	$1500
Prana Biotechnology Limited – Product Pipeline Review – 2012 By Global Markets Direct Prana Biotechnology Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Prana Biotechnology Limited - Product Pipeline Review - 2012” provides data on the Prana Biotechnology Limited’s research and	August 2012	$1500
ProMetic Life Sciences Inc. – Product Pipeline Review – 2012 By Global Markets Direct ProMetic Life Sciences Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “ProMetic Life Sciences Inc. - Product Pipeline Review - 2012” provides data on the ProMetic Life Sciences Inc.’s research and	August 2012	$1500
Raptor Pharmaceuticals Corp. – Product Pipeline Review – 2012 By Global Markets Direct Raptor Pharmaceuticals Corp. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Raptor Pharmaceuticals Corp. - Product Pipeline Review - 2012” provides data on the Raptor Pharmaceuticals Corp.’s research a	August 2012	$1500
RaQualia Pharma Inc. – Product Pipeline Review – 2012 By Global Markets Direct RaQualia Pharma Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “RaQualia Pharma Inc. - Product Pipeline Review - 2012” provides data on the RaQualia Pharma Inc.’s research and development focus. Th	August 2012	$1500
Repligen Corporation – Product Pipeline Review – 2012 By Global Markets Direct Repligen Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Repligen Corporation - Product Pipeline Review - 2012” provides data on the Repligen Corporation’s research and development focus. Th	August 2012	$1500
Rexahn Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Rexahn Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Rexahn Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Rexahn Pharmaceuticals, Inc.’s research a	August 2012	$1500
Santaris Pharma A/S – Product Pipeline Review – 2012 By Global Markets Direct Santaris Pharma A/S – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Santaris Pharma A/S - Product Pipeline Review - 2012” provides data on the Santaris Pharma A/S’s research and development focus. The r	August 2012	$1500
Spherix Incorporated – Product Pipeline Review – 2012 By Global Markets Direct Spherix Incorporated – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Spherix Incorporated - Product Pipeline Review - 2012” provides data on the Spherix Incorporated’s research and development focus. Th	August 2012	$1500
Teva Pharmaceutical Industries Limited – Product Pipeline Review – 2012 By Global Markets Direct Teva Pharmaceutical Industries Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Teva Pharmaceutical Industries Limited - Product Pipeline Review - 2012” provides data on the Teva Pharmaceutical I	August 2012	$1500
MacroGenics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct MacroGenics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “MacroGenics, Inc. - Product Pipeline Review - 2012” provides data on the MacroGenics, Inc.’s research and development focus. The report	August 2012	$1500
TopoTarget A/S – Product Pipeline Review – 2012 By Global Markets Direct TopoTarget A/S – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “TopoTarget A/S - Product Pipeline Review - 2012” provides data on the TopoTarget A/S’s research and development focus. The report includes	August 2012	$1500
YM BioSciences Inc. – Product Pipeline Review – 2012 By Global Markets Direct YM BioSciences Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “YM BioSciences Inc. - Product Pipeline Review - 2012” provides data on the YM BioSciences Inc.’s research and development focus. The r	August 2012	$1500
ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012 By Global Markets Direct ZIOPHARM Oncology, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “ZIOPHARM Oncology, Inc. - Product Pipeline Review - 2012” provides data on the ZIOPHARM Oncology, Inc.’s research and development	August 2012	$1500
Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012 By Global Markets Direct Zydus Cadila Healthcare Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Zydus Cadila Healthcare Limited - Product Pipeline Review - 2012” provides data on the Zydus Cadila Healthcare Limited’s r	August 2012	$1500
Acucela Inc. – Product Pipeline Review – 2012 By Global Markets Direct Acucela Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Acucela Inc. - Product Pipeline Review - 2012” provides data on the Acucela Inc.’s research and development focus. The report includes inform	August 2012	$1500
Aldagen, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Aldagen, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Aldagen, Inc. - Product Pipeline Review - 2012” provides data on the Aldagen, Inc.’s research and development focus. The report includes inf	August 2012	$1500
Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Bellicum Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Bellicum Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Bellicum Pharmaceuticals, Inc.’s rese	August 2012	$1500
DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct DiaKine Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “DiaKine Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the DiaKine Therapeutics, Inc.’s research and dev	August 2012	$1500
Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012 By Global Markets Direct Dong-A Pharmaceutical Co., Ltd. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Dong-A Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012” provides data on the Dong-A Pharmaceutical Co., Ltd.’s r	August 2012	$1500
NOXXON Pharma AG – Product Pipeline Review – 2012 By Global Markets Direct NOXXON Pharma AG – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “NOXXON Pharma AG - Product Pipeline Review - 2012” provides data on the NOXXON Pharma AG’s research and development focus. The report inc	August 2012	$1500
Proacta, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Proacta, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Proacta, Inc. - Product Pipeline Review - 2012” provides data on the Proacta, Inc.’s research and development focus. The report includes inf	August 2012	$1500
Thrasos, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Thrasos, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Thrasos, Inc. - Product Pipeline Review - 2012” provides data on the Thrasos, Inc.’s research and development focus. The report includes inf	August 2012	$1500
Wellstat Therapeutics Corporation – Product Pipeline Review – 2012 By Global Markets Direct Wellstat Therapeutics Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Wellstat Therapeutics Corporation - Product Pipeline Review - 2012” provides data on the Wellstat Therapeutics Corporati	August 2012	$1500
Biomay AG – Product Pipeline Review – 2012 By Global Markets Direct Biomay AG – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biomay AG - Product Pipeline Review - 2012” provides data on the Biomay AG’s research and development focus. The report includes information on	August 2012	$1500
Cell Therapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Cell Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Cell Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the Cell Therapeutics, Inc.’s research and development	August 2012	$1500
Cortex Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Cortex Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Cortex Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Cortex Pharmaceuticals, Inc.’s research a	August 2012	$1500
Genmab A/S – Product Pipeline Review – 2012 By Global Markets Direct Genmab A/S – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Genmab A/S - Product Pipeline Review - 2012” provides data on the Genmab A/S’s research and development focus. The report includes information	August 2012	$1500
Genocea Biosciences, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Genocea Biosciences, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Genocea Biosciences, Inc. - Product Pipeline Review - 2012” provides data on the Genocea Biosciences, Inc.’s research and develo	August 2012	$1500
Halozyme Therapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Halozyme Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Halozyme Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the Halozyme Therapeutics, Inc.’s research and	August 2012	$1500
HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012 By Global Markets Direct HanAll Biopharma Co., Ltd. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “HanAll Biopharma Co., Ltd. - Product Pipeline Review - 2012” provides data on the HanAll Biopharma Co., Ltd.’s research and dev	August 2012	$1500
Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Idenix Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Idenix Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Idenix Pharmaceuticals, Inc.’s research a	August 2012	$1500
Incyte Corporation – Product Pipeline Review – 2012 By Global Markets Direct Incyte Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Incyte Corporation - Product Pipeline Review - 2012” provides data on the Incyte Corporation’s research and development focus. The repo	August 2012	$1500
IntelGenx Corp. – Product Pipeline Review – 2012 By Global Markets Direct IntelGenx Corp. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “IntelGenx Corp. - Product Pipeline Review - 2012” provides data on the IntelGenx Corp.’s research and development focus. The report includ	August 2012	$1500
Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Isis Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Isis Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Isis Pharmaceuticals, Inc.’s research and dev	August 2012	$1500
JADO Technologies GmbH – Product Pipeline Review – 2012 By Global Markets Direct JADO Technologies GmbH – Product Pipeline Review – 2012SummaryGlobal Markets Direct’s pharmaceuticals report, JADO Technologies GmbH - Product Pipeline Review - 2012” provides data on the JADO...	August 2012	$1500
Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Ligand Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Ligand Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Ligand Pharmaceuticals, Inc.’s research a	August 2012	$1500
NeuroSearch A/S – Product Pipeline Review – 2012 By Global Markets Direct NeuroSearch A/S – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “NeuroSearch A/S - Product Pipeline Review - 2012” provides data on the NeuroSearch A/S’s research and development focus. The report includ	August 2012	$1500
NovaDel Pharma, Inc. – Product Pipeline Review – 2012 By Global Markets Direct NovaDel Pharma, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “NovaDel Pharma, Inc. - Product Pipeline Review - 2012” provides data on the NovaDel Pharma, Inc.’s research and development focus. Th	August 2012	$1500
Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Portola Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Portola Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Portola Pharmaceuticals, Inc.’s researc	August 2012	$1500
Rigel Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Rigel Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Rigel Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Rigel Pharmaceuticals, Inc.’s research and	August 2012	$1500
Seek – Product Pipeline Review – 2012 By Global Markets Direct Seek – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “SEEK - Product Pipeline Review - 2012” provides data on the SEEK’s research and development focus. The report includes information on current develop	August 2012	$1500
Sinovac Biotech Ltd. – Product Pipeline Review – 2012 By Global Markets Direct Sinovac Biotech Ltd. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Sinovac Biotech Ltd. - Product Pipeline Review - 2012” provides data on the Sinovac Biotech Ltd.’s research and development focus. Th	August 2012	$1500
Stallergenes S.A. – Product Pipeline Review – 2012 By Global Markets Direct Stallergenes S.A. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Stallergenes S.A. - Product Pipeline Review - 2012” provides data on the Stallergenes S.A.’s research and development focus. The report	August 2012	$1500
Vernalis plc – Product Pipeline Review – 2012 By Global Markets Direct Vernalis plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Vernalis plc - Product Pipeline Review - 2012” provides data on the Vernalis plc’s research and development focus. The report includes inform	August 2012	$1500
Active Biotech AB – Product Pipeline Review – 2012 By Global Markets Direct Active Biotech AB – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Active Biotech AB - Product Pipeline Review - 2012” provides data on the Active Biotech AB’s research and development focus. The report	August 2012	$1500
Advenchen Laboratories, LLC – Product Pipeline Review – 2012 By Global Markets Direct Advenchen Laboratories, LLC – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Advenchen Laboratories, LLC - Product Pipeline Review - 2012” provides data on the Advenchen Laboratories, LLC’s research and	August 2012	$1500
Affichem – Product Pipeline Review – 2012 By Global Markets Direct Affichem – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Affichem - Product Pipeline Review - 2012” provides data on the Affichem’s research and development focus. The report includes information on cur	August 2012	$1500
Allergy Therapeutics plc – Product Pipeline Review – 2012 By Global Markets Direct Allergy Therapeutics plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Allergy Therapeutics plc - Product Pipeline Review - 2012” provides data on the Allergy Therapeutics plc’s research and developme	August 2012	$1500
Am-Pharma B.V. – Product Pipeline Review – 2012 By Global Markets Direct Am-Pharma B.V. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Am-Pharma B.V. - Product Pipeline Review - 2012” provides data on the Am-Pharma B.V.’s research and development focus. The report includes	August 2012	$1500
Anacor Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Anacor Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Anacor Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Anacor Pharmaceuticals, Inc.’s research a	August 2012	$1500
Angion Biomedica Corp. – Product Pipeline Review – 2012 By Global Markets Direct Angion Biomedica Corp. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Angion Biomedica Corp. - Product Pipeline Review - 2012” provides data on the Angion Biomedica Corp.’s research and development foc	August 2012	$1500
Anthera Pharmaceuticals‚ Inc. – Product Pipeline Review – 2012 By Global Markets Direct Anthera Pharmaceuticals‚ Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Anthera Pharmaceuticals‚ Inc. - Product Pipeline Review - 2012” provides data on the Anthera Pharmaceuticals‚ Inc.’s researc	August 2012	$1500
Applied Genetic Technologies Corporation – Product Pipeline Review – 2012 By Global Markets Direct Applied Genetic Technologies Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Applied Genetic Technologies Corporation - Product Pipeline Review - 2012” provides data on the Applied Genetic T	August 2012	$1500
Apricus Biosciences, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Apricus Biosciences, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Apricus Biosciences, Inc. - Product Pipeline Review - 2012” provides data on the Apricus Biosciences, Inc.’s research and develo	August 2012	$1500
Aradigm Corporation – Product Pipeline Review – 2012 By Global Markets Direct Aradigm Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Aradigm Corporation - Product Pipeline Review - 2012” provides data on the Aradigm Corporation’s research and development focus. The r	August 2012	$1500
aRigen Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct aRigen Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “aRigen Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the aRigen Pharmaceuticals, Inc.’s research a	August 2012	$1500
ArmaGen Technologies, Inc. – Product Pipeline Review – 2012 By Global Markets Direct ArmaGen Technologies, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “ArmaGen Technologies, Inc. - Product Pipeline Review - 2012” provides data on the ArmaGen Technologies, Inc.’s research and dev	August 2012	$1500
Bavarian Nordic A/S – Product Pipeline Review – 2012 By Global Markets Direct Bavarian Nordic A/S – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Bavarian Nordic A/S - Product Pipeline Review - 2012” provides data on the Bavarian Nordic A/S’s research and development focus. The r	August 2012	$1500
BioAlliance Pharma SA – Product Pipeline Review – 2012 By Global Markets Direct BioAlliance Pharma SA – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “BioAlliance Pharma SA - Product Pipeline Review - 2012” provides data on the BioAlliance Pharma SA’s research and development focus.	August 2012	$1500
Biocon Limited – Product Pipeline Review – 2012 By Global Markets Direct Biocon Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biocon Limited - Product Pipeline Review - 2012” provides data on the Biocon Limited’s research and development focus. The report includes	August 2012	$1500
Biofrontera AG – Product Pipeline Review – 2012 By Global Markets Direct Biofrontera AG – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biofrontera AG - Product Pipeline Review - 2012” provides data on the Biofrontera AG’s research and development focus. The report includes	August 2012	$1500
Biovista Inc. – Product Pipeline Review – 2012 By Global Markets Direct Biovista Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biovista Inc. - Product Pipeline Review - 2012” provides data on the Biovista Inc.’s research and development focus. The report includes inf	August 2012	$1500
CHONG KUN DANG PHARMACEUTICAL CORP. – Product Pipeline Review – 2012 By Global Markets Direct CHONG KUN DANG PHARMACEUTICAL CORP. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “CHONG KUN DANG PHARMACEUTICAL CORP. - Product Pipeline Review - 2012” provides data on the CHONG KUN DANG PHARMACEUTIC	August 2012	$1500
Cosmo Pharmaceuticals S.p.A – Product Pipeline Review – 2012 By Global Markets Direct Cosmo Pharmaceuticals S.p.A – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Cosmo Pharmaceuticals S.p.A - Product Pipeline Review - 2012” provides data on the Cosmo Pharmaceuticals S.p.A’s research and	August 2012	$1500
CREABILIS Therapeutics S.r.l. – Product Pipeline Review – 2012 By Global Markets Direct CREABILIS Therapeutics S.r.l. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “CREABILIS Therapeutics S.r.l. - Product Pipeline Review - 2012” provides data on the CREABILIS Therapeutics S.r.l.’s researc	August 2012	$1500
Domain Therapeutics – Product Pipeline Review – 2012 By Global Markets Direct Domain Therapeutics – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Domain Therapeutics - Product Pipeline Review - 2012” provides data on the Domain Therapeutics’s research and development focus. The r	August 2012	$1500
Dynavax Technologies Corporation – Product Pipeline Review – 2012 By Global Markets Direct Dynavax Technologies Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Dynavax Technologies Corporation - Product Pipeline Review - 2012” provides data on the Dynavax Technologies Corporation’	August 2012	$1500
Endotis Pharma – Product Pipeline Review – 2012 By Global Markets Direct Endotis Pharma – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Endotis Pharma - Product Pipeline Review - 2012” provides data on the Endotis Pharma’s research and development focus. The report includes	August 2012	$1500
EntreMed, Inc. – Product Pipeline Review – 2012 By Global Markets Direct EntreMed, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “EntreMed, Inc. - Product Pipeline Review - 2012” provides data on the EntreMed, Inc.’s research and development focus. The report includes	August 2012	$1500
EpiCept Corporation – Product Pipeline Review – 2012 By Global Markets Direct EpiCept Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “EpiCept Corporation - Product Pipeline Review - 2012” provides data on the EpiCept Corporation’s research and development focus. The r	August 2012	$1500
Heat Biologics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Heat Biologics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Heat Biologics, Inc. - Product Pipeline Review - 2012” provides data on the Heat Biologics, Inc.’s research and development focus. Th	August 2012	$1500
Helix BioMedix, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Helix BioMedix, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Helix BioMedix, Inc. - Product Pipeline Review - 2012” provides data on the Helix BioMedix, Inc.’s research and development focus. Th	August 2012	$1500
Hemispherx Biopharma, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Hemispherx Biopharma, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Hemispherx Biopharma, Inc. - Product Pipeline Review - 2012” provides data on the Hemispherx Biopharma, Inc.’s research and dev	August 2012	$1500
HRA Pharma, SA – Product Pipeline Review – 2012 By Global Markets Direct HRA Pharma, SA – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “HRA Pharma, SA - Product Pipeline Review - 2012” provides data on the HRA Pharma, SA’s research and development focus. The report includes	August 2012	$1500
Imaxio – Product Pipeline Review – 2012 By Global Markets Direct Imaxio – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Imaxio - Product Pipeline Review - 2012” provides data on the Imaxio’s research and development focus. The report includes information on current d	August 2012	$1500
Immunovaccine, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Immunovaccine, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Immunovaccine, Inc. - Product Pipeline Review - 2012” provides data on the Immunovaccine, Inc.’s research and development focus. The r	August 2012	$1500
InSite Vision Incorporated – Product Pipeline Review – 2012 By Global Markets Direct InSite Vision Incorporated – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “InSite Vision Incorporated - Product Pipeline Review - 2012” provides data on the InSite Vision Incorporated’s research and dev	August 2012	$1500
INSYS Therapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct INSYS Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “INSYS Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the INSYS Therapeutics, Inc.’s research and developme	August 2012	$1500
Intercell AG – Product Pipeline Review – 2012 By Global Markets Direct Intercell AG – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Intercell AG - Product Pipeline Review - 2012” provides data on the Intercell AG’s research and development focus. The report includes inform	August 2012	$1500
InterMune, Inc. – Product Pipeline Review – 2012 By Global Markets Direct InterMune, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “InterMune, Inc. - Product Pipeline Review - 2012” provides data on the InterMune, Inc.’s research and development focus. The report includ	August 2012	$1500
InVasc Therapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct InVasc Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “InVasc Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the InVasc Therapeutics, Inc.’s research and develo	August 2012	$1500
ISA Pharmaceuticals B.V. – Product Pipeline Review – 2012 By Global Markets Direct ISA Pharmaceuticals B.V. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “ISA Pharmaceuticals B.V. - Product Pipeline Review - 2012” provides data on the ISA Pharmaceuticals B.V.’s research and developme	August 2012	$1500
Karo Bio – Product Pipeline Review – 2012 By Global Markets Direct Karo Bio – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Karo Bio - Product Pipeline Review - 2012” provides data on the Karo Bio’s research and development focus. The report includes information on cur	August 2012	$1500
KemPharm, Inc. – Product Pipeline Review – 2012 By Global Markets Direct KemPharm, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “KemPharm, Inc. - Product Pipeline Review - 2012” provides data on the KemPharm, Inc.’s research and development focus. The report includes	August 2012	$1500
Merck KGaA – Product Pipeline Review – 2012 By Global Markets Direct Merck KGaA – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Merck KGaA - Product Pipeline Review - 2012” provides data on the Merck KGaA’s research and development focus. The report includes information	August 2012	$1500
Lipopharma Therapeutics SL – Product Pipeline Review – 2012 By Global Markets Direct Lipopharma Therapeutics SL – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Lipopharma Therapeutics SL - Product Pipeline Review - 2012” provides data on the Lipopharma Therapeutics SL’s research and dev	August 2012	$1500
Oxford BioMedica plc – Product Pipeline Review – 2012 By Global Markets Direct Oxford BioMedica plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Oxford BioMedica plc - Product Pipeline Review - 2012” provides data on the Oxford BioMedica plc’s research and development focus. Th	August 2012	$1500
MediPost Co., Ltd. – Product Pipeline Review – 2012 By Global Markets Direct MediPost Co., Ltd. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “MediPost Co., Ltd. - Product Pipeline Review - 2012” provides data on the MediPost Co., Ltd.’s research and development focus. The repo	August 2012	$1500
3SBio Inc. – Product Pipeline Review – 2012 By Global Markets Direct 3SBio Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “3SBio Inc. - Product Pipeline Review - 2012” provides data on the 3SBio Inc.’s research and development focus. The report includes information	August 2012	$1500
miRagen Therapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct miRagen Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “miRagen Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the miRagen Therapeutics, Inc.’s research and dev	August 2012	$1500
MultiCell Technologies, Inc. – Product Pipeline Review – 2012 By Global Markets Direct MultiCell Technologies, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “MultiCell Technologies, Inc. - Product Pipeline Review - 2012” provides data on the MultiCell Technologies, Inc.’s research a	August 2012	$1500
Mymetics Corporation – Product Pipeline Review – 2012 By Global Markets Direct Mymetics Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Mymetics Corporation - Product Pipeline Review - 2012” provides data on the Mymetics Corporation’s research and development focus. Th	August 2012	$1500
NeurogesX, Inc. – Product Pipeline Review – 2012 By Global Markets Direct NeurogesX, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “NeurogesX, Inc. - Product Pipeline Review - 2012” provides data on the NeurogesX, Inc.’s research and development focus. The report includ	August 2012	$1500
Northwest Biotherapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Northwest Biotherapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Northwest Biotherapeutics, Inc. - Product Pipeline Review - 2012” provides data on the Northwest Biotherapeutics, Inc.’s r	August 2012	$1500
Noscira, S.A. – Product Pipeline Review – 2012 By Global Markets Direct Noscira, S.A. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Noscira, S.A. - Product Pipeline Review - 2012” provides data on the Noscira, S.A.’s research and development focus. The report includes inf	August 2012	$1500
Obio Pharmaceutical Holdings Limited – Product Pipeline Review – 2012 By Global Markets Direct Obio Pharmaceutical Holdings Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Obio Pharmaceutical Holdings Limited - Product Pipeline Review - 2012” provides data on the Obio Pharmaceutical Holdi	August 2012	$1500
Oncolytics Biotech Inc. – Product Pipeline Review – 2012 By Global Markets Direct Oncolytics Biotech Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Oncolytics Biotech Inc. - Product Pipeline Review - 2012” provides data on the Oncolytics Biotech Inc.’s research and development	August 2012	$1500
Oncothyreon Inc. – Product Pipeline Review – 2012 By Global Markets Direct Oncothyreon Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Oncothyreon Inc. - Product Pipeline Review - 2012” provides data on the Oncothyreon Inc.’s research and development focus. The report inc	August 2012	$1500
OncoVista Innovative Therapies, Inc. – Product Pipeline Review – 2012 By Global Markets Direct OncoVista Innovative Therapies, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “OncoVista Innovative Therapies, Inc. - Product Pipeline Review - 2012” provides data on the OncoVista Innovative Ther	August 2012	$1500
OPKO Health, Inc. – Product Pipeline Review – 2012 By Global Markets Direct OPKO Health, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “OPKO Health, Inc. - Product Pipeline Review - 2012” provides data on the OPKO Health, Inc.’s research and development focus. The report	August 2012	$1500
Patrys Limited – Product Pipeline Review – 2012 By Global Markets Direct Patrys Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Patrys Limited - Product Pipeline Review - 2012” provides data on the Patrys Limited’s research and development focus. The report includes	August 2012	$1500
Almirall, S.A. – Product Pipeline Review – 2012 By Global Markets Direct Almirall, S.A. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Almirall, S.A. - Product Pipeline Review - 2012” provides data on the Almirall, S.A.’s research and development focus. The report includes	August 2012	$1500
Proximagen Group plc – Product Pipeline Review – 2012 By Global Markets Direct Proximagen Group plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Proximagen Group plc - Product Pipeline Review - 2012” provides data on the Proximagen Group plc’s research and development focus. Th	August 2012	$1500
Sangamo BioSciences, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Sangamo BioSciences, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Sangamo BioSciences, Inc. - Product Pipeline Review - 2012” provides data on the Sangamo BioSciences, Inc.’s research and develo	August 2012	$1500
Siena Biotech S.p.A. – Product Pipeline Review – 2012 By Global Markets Direct Siena Biotech S.p.A. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Siena Biotech S.p.A. - Product Pipeline Review - 2012” provides data on the Siena Biotech S.p.A.’s research and development focus. Th	August 2012	$1500
SIGA Technologies, Inc. – Product Pipeline Review – 2012 By Global Markets Direct SIGA Technologies, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “SIGA Technologies, Inc. - Product Pipeline Review - 2012” provides data on the SIGA Technologies, Inc.’s research and development	August 2012	$1500
Silence Therapeutics plc – Product Pipeline Review – 2012 By Global Markets Direct Silence Therapeutics plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Silence Therapeutics plc - Product Pipeline Review - 2012” provides data on the Silence Therapeutics plc’s research and developme	August 2012	$1500
Simcere Pharmaceutical Group – Product Pipeline Review – 2012 By Global Markets Direct Simcere Pharmaceutical Group – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Simcere Pharmaceutical Group - Product Pipeline Review - 2012” provides data on the Simcere Pharmaceutical Group’s research a	August 2012	$1500
Soligenix, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Soligenix, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Soligenix, Inc. - Product Pipeline Review - 2012” provides data on the Soligenix, Inc.’s research and development focus. The report includ	August 2012	$1500
Stempeutics Research Private Limited – Product Pipeline Review – 2012 By Global Markets Direct Stempeutics Research Private Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Stempeutics Research Private Limited - Product Pipeline Review - 2012” provides data on the Stempeutics Research Priv	August 2012	$1500
Sucampo Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Sucampo Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Sucampo Pharmaceuticals, Inc.’s researc	August 2012	$1500
Sunesis Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Sunesis Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Sunesis Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Sunesis Pharmaceuticals, Inc.’s researc	August 2012	$1500
Synthetic Biologics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Synthetic Biologics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Synthetic Biologics, Inc. - Product Pipeline Review - 2012” provides data on the Synthetic Biologics, Inc.’s research and develo	August 2012	$1500
TauRx Therapeutics Ltd – Product Pipeline Review – 2012 By Global Markets Direct TauRx Therapeutics Ltd – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “TauRx Therapeutics Ltd - Product Pipeline Review - 2012” provides data on the TauRx Therapeutics Ltd’s research and development foc	August 2012	$1500
Theracos, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Theracos, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Theracos, Inc. - Product Pipeline Review - 2012” provides data on the Theracos, Inc.’s research and development focus. The report includes	August 2012	$1500
Theravance, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Theravance, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Theravance, Inc. - Product Pipeline Review - 2012” provides data on the Theravance, Inc.’s research and development focus. The report inc	August 2012	$1500
VaxInnate Corporation – Product Pipeline Review – 2012 By Global Markets Direct VaxInnate Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “VaxInnate Corporation - Product Pipeline Review - 2012” provides data on the VaxInnate Corporation’s research and development focus.	August 2012	$1500
VIVUS, Inc. – Product Pipeline Review – 2012 By Global Markets Direct VIVUS, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “VIVUS, Inc. - Product Pipeline Review - 2012” provides data on the VIVUS, Inc.’s research and development focus. The report includes informati	August 2012	$1500
Welichem Biotech Inc. – Product Pipeline Review – 2012 By Global Markets Direct Welichem Biotech Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Welichem Biotech Inc. - Product Pipeline Review - 2012” provides data on the Welichem Biotech Inc.’s research and development focus.	August 2012	$1500
XenoPort, Inc. – Product Pipeline Review – 2012 By Global Markets Direct XenoPort, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “XenoPort, Inc. - Product Pipeline Review - 2012” provides data on the XenoPort, Inc.’s research and development focus. The report includes	August 2012	$1500
ARCA biopharma, Inc. – Product Pipeline Review – 2012 By Global Markets Direct ARCA biopharma, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “ARCA biopharma, Inc. - Product Pipeline Review - 2012” provides data on the ARCA biopharma, Inc.’s research and development focus. Th	August 2012	$1500
BrainCells Inc. – Product Pipeline Review – 2012 By Global Markets Direct BrainCells Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “BrainCells Inc. - Product Pipeline Review - 2012” provides data on the BrainCells Inc.’s research and development focus. The report includ	August 2012	$1500
Funxional Therapeutics Ltd – Product Pipeline Review – 2012 By Global Markets Direct Funxional Therapeutics Ltd – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Funxional Therapeutics Ltd - Product Pipeline Review - 2012” provides data on the Funxional Therapeutics Ltd’s research and dev	August 2012	$1500
Icagen, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Icagen, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Icagen, Inc. - Product Pipeline Review - 2012” provides data on the Icagen, Inc.’s research and development focus. The report includes inform	August 2012	$1500
Trius Therapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Trius Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Trius Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the Trius Therapeutics, Inc.’s research and developme	August 2012	$1500
AlphaRx, Inc. – Product Pipeline Review – 2012 By Global Markets Direct AlphaRx, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “AlphaRx, Inc. - Product Pipeline Review - 2012” provides data on the AlphaRx, Inc.’s research and development focus. The report includes inf	August 2012	$1500
Amicus Therapeutics, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Amicus Therapeutics, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Amicus Therapeutics, Inc. - Product Pipeline Review - 2012” provides data on the Amicus Therapeutics, Inc.’s research and develo	August 2012	$1500
AndroScience Corporation – Product Pipeline Review – 2012 By Global Markets Direct AndroScience Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “AndroScience Corporation - Product Pipeline Review - 2012” provides data on the AndroScience Corporation’s research and developme	August 2012	$1500
Athersys, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Athersys, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Athersys, Inc. - Product Pipeline Review - 2012” provides data on the Athersys, Inc.’s research and development focus. The report includes	August 2012	$1500
Charlesson LLC. – Product Pipeline Review – 2012 By Global Markets Direct Charlesson LLC. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Charlesson LLC. - Product Pipeline Review - 2012” provides data on the Charlesson LLC.’s research and development focus. The report includ	August 2012	$1500
Gedeon Richter Plc – Product Pipeline Review – 2012 By Global Markets Direct Gedeon Richter Plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Gedeon Richter Plc - Product Pipeline Review - 2012” provides data on the Gedeon Richter Plc’s research and development focus. The repo	August 2012	$1500
PAION AG – Product Pipeline Review – 2012 By Global Markets Direct PAION AG – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “PAION AG - Product Pipeline Review - 2012” provides data on the PAION AG’s research and development focus. The report includes information on cur	August 2012	$1500
PharmAthene, Inc. – Product Pipeline Review – 2012 By Global Markets Direct PharmAthene, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “PharmAthene, Inc. - Product Pipeline Review - 2012” provides data on the PharmAthene, Inc.’s research and development focus. The report	August 2012	$1500
SANWA KAGAKU KENKYUSHO CO.,LTD. – Product Pipeline Review – 2012 By Global Markets Direct SANWA KAGAKU KENKYUSHO CO.,LTD. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “SANWA KAGAKU KENKYUSHO CO.,LTD. - Product Pipeline Review - 2012” provides data on the SANWA KAGAKU KENKYUSHO CO.,LTD.’s r	August 2012	$1500
Warner Chilcott Plc – Product Pipeline Review – 2012 By Global Markets Direct Warner Chilcott Plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Warner Chilcott Plc - Product Pipeline Review - 2012” provides data on the Warner Chilcott Plc’s research and development focus. The r	August 2012	$1500
Proneuron Biotechnologies, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Proneuron Biotechnologies, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Proneuron Biotechnologies, Inc. - Product Pipeline Review - 2012” provides data on the Proneuron Biotechnologies, Inc.’s r	August 2012	$1500
Supratek Pharma Inc. – Product Pipeline Review – 2012 By Global Markets Direct Supratek Pharma Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Supratek Pharma Inc. - Product Pipeline Review - 2012” provides data on the Supratek Pharma Inc.’s research and development focus. Th	August 2012	$1500
UMN Pharma Inc. – Product Pipeline Review – 2012 By Global Markets Direct UMN Pharma Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “UMN Pharma Inc. - Product Pipeline Review - 2012” provides data on the UMN Pharma Inc.’s research and development focus. The report includ	August 2012	$1500
Xel Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Xel Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Xel Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Xel Pharmaceuticals, Inc.’s research and develo	August 2012	$1500
Biogen Idec Inc. – Product Pipeline Review – 2012 By Global Markets Direct Biogen Idec Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Biogen Idec Inc. - Product Pipeline Review - 2012” provides data on the Biogen Idec Inc.’s research and development focus. The report inc	August 2012	$1500
AEterna Zentaris Inc. – Product Pipeline Review – 2012 By Global Markets Direct AEterna Zentaris Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “AEterna Zentaris Inc. - Product Pipeline Review - 2012” provides data on the AEterna Zentaris Inc.’s research and development focus.	August 2012	$1500
Genfit – Product Pipeline Review – 2012 By Global Markets Direct Genfit – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Genfit - Product Pipeline Review - 2012” provides data on the Genfit’s research and development focus. The report includes information on current d	August 2012	$1500
A. Menarini Industrie Farmaceutiche Riunite Srl – Product Pipeline Review – 2012 By Global Markets Direct A. Menarini Industrie Farmaceutiche Riunite Srl – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “A. Menarini Industrie Farmaceutiche Riunite Srl - Product Pipeline Review - 2012” provides data on the A.	August 2012	$1500
Paratek Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Paratek Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Paratek Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Paratek Pharmaceuticals, Inc.’s researc	August 2012	$1500
Collegium Pharmaceutical, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Collegium Pharmaceutical, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Collegium Pharmaceutical, Inc. - Product Pipeline Review - 2012” provides data on the Collegium Pharmaceutical, Inc.’s rese	August 2012	$1500
Adventrx Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Adventrx Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Adventrx Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Adventrx Pharmaceuticals, Inc.’s rese	August 2012	$1500
Inotek Pharmaceuticals Corporation – Product Pipeline Review – 2012 By Global Markets Direct Inotek Pharmaceuticals Corporation – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Inotek Pharmaceuticals Corporation - Product Pipeline Review - 2012” provides data on the Inotek Pharmaceuticals Corpor	August 2012	$1500
Fina Biotech – Product Pipeline Review – 2012 By Global Markets Direct Fina Biotech – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Fina Biotech - Product Pipeline Review - 2012” provides data on the Fina Biotech’s research and development focus. The report includes inform	August 2012	$1500
Archer Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Archer Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Archer Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Archer Pharmaceuticals, Inc.’s research a	August 2012	$1500
Gene Signal International SA. – Product Pipeline Review – 2012 By Global Markets Direct Gene Signal International SA. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Gene Signal International SA. - Product Pipeline Review - 2012” provides data on the Gene Signal International SA.’s researc	August 2012	$1500
Panacea Biotec Limited – Product Pipeline Review – 2012 By Global Markets Direct Panacea Biotec Limited – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Panacea Biotec Limited - Product Pipeline Review - 2012” provides data on the Panacea Biotec Limited’s research and development foc	August 2012	$1500
IMPAX Laboratories, Inc. – Product Pipeline Review – 2012 By Global Markets Direct IMPAX Laboratories, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “IMPAX Laboratories, Inc. - Product Pipeline Review - 2012” provides data on the IMPAX Laboratories, Inc.’s research and developme	August 2012	$1500
Actis Biologics, Inc – Product Pipeline Review – 2012 By Global Markets Direct Actis Biologics, Inc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Actis Biologics, Inc - Product Pipeline Review - 2012” provides data on the Actis Biologics, Inc’s research and development focus. Th	August 2012	$1500
Exonhit S.A. – Product Pipeline Review – 2012 By Global Markets Direct Exonhit S.A. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Exonhit S.A. - Product Pipeline Review - 2012” provides data on the Exonhit S.A.’s research and development focus. The report includes inform	August 2012	$1500
Santarus, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Santarus, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Santarus, Inc. - Product Pipeline Review - 2012” provides data on the Santarus, Inc.’s research and development focus. The report includes	August 2012	$1500
Enzo Biochem, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Enzo Biochem, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Enzo Biochem, Inc. - Product Pipeline Review - 2012” provides data on the Enzo Biochem, Inc.’s research and development focus. The repo	August 2012	$1500
Exelixis, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Exelixis, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Exelixis, Inc. - Product Pipeline Review - 2012” provides data on the Exelixis, Inc.’s research and development focus. The report includes	August 2012	$1500
GW Pharmaceuticals plc – Product Pipeline Review – 2012 By Global Markets Direct GW Pharmaceuticals plc – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “GW Pharmaceuticals plc - Product Pipeline Review - 2012” provides data on the GW Pharmaceuticals plc’s research and development foc	August 2012	$1500
Human Genome Sciences, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Human Genome Sciences, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Human Genome Sciences, Inc. - Product Pipeline Review - 2012” provides data on the Human Genome Sciences, Inc.’s research and	August 2012	$1500
Idera Pharmaceuticals, Inc. – Product Pipeline Review – 2012 By Global Markets Direct Idera Pharmaceuticals, Inc. – Product Pipeline Review – 2012 Summary Global Markets Direct’s pharmaceuticals report, “Idera Pharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Idera Pharmaceuticals, Inc.’s research and	August 2012	$1500
Prostate Cancer – Pipeline Review, H2 2012 By Global Markets Direct Prostate Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Prostate Cancer - Pipeline Review, H2 2012'', provides an overview of the Prostate Cancer therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2500
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) – Pipeline Review, H2 2012 By Global Markets Direct Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2012'', provides an overview of the Acut	August 2012	$2500
Head And Neck Cancer – Pipeline Review, H2 2012 By Global Markets Direct Head And Neck Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Head And Neck Cancer - Pipeline Review, H2 2012'', provides an overview of the Head And Neck Cancer therapeutic pipeline. This report provides information on the t	August 2012	$2500
Non-Hodgkin Lymphoma – Pipeline Review, H2 2012 By Global Markets Direct Non-Hodgkin Lymphoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Non-Hodgkin Lymphoma - Pipeline Review, H2 2012'', provides an overview of the Non-Hodgkin Lymphoma therapeutic pipeline. This report provides information on the t	August 2012	$2500
Hepatitis – Pipeline Review, H2 2012 By Global Markets Direct Hepatitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hepatitis - Pipeline Review, H2 2012'', provides an overview of the Hepatitis therapeutic pipeline. This report provides information on the therapeutic development for Hepati	August 2012	$2500
Melanoma – Pipeline Review, H2 2012 By Global Markets Direct Melanoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Melanoma - Pipeline Review, H2 2012'', provides an overview of the Melanoma therapeutic pipeline. This report provides information on the therapeutic development for Melanoma,	August 2012	$2500
Type 2 Diabetes – Pipeline Review, H2 2012 By Global Markets Direct Type 2 Diabetes – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Type 2 Diabetes - Pipeline Review, H2 2012'', provides an overview of the Type 2 Diabetes therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2500
Alzheimer's Disease – Pipeline Review, H2 2012 By Global Markets Direct Alzheimer''s Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Alzheimer''s Disease - Pipeline Review, H2 2012'', provides an overview of the Alzheimer''s Disease therapeutic pipeline. This report provides information on the ther	August 2012	$2500
Rheumatoid Arthritis – Pipeline Review, H2 2012 By Global Markets Direct Rheumatoid Arthritis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Rheumatoid Arthritis - Pipeline Review, H2 2012'', provides an overview of the Rheumatoid Arthritis therapeutic pipeline. This report provides information on the t	August 2012	$2500
Hepatitis C – Pipeline Review, H2 2012 By Global Markets Direct Hepatitis C – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hepatitis C - Pipeline Review, H2 2012'', provides an overview of the Hepatitis C therapeutic pipeline. This report provides information on the therapeutic development for	August 2012	$2500
Influenza – Pipeline Review, H2 2012 By Global Markets Direct Influenza – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Influenza - Pipeline Review, H2 2012'', provides an overview of the Influenza therapeutic pipeline. This report provides information on the therapeutic development for Influe	August 2012	$2500
Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2012 By Global Markets Direct Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2012'', provides an overview of the Chronic Obstructive Pulmonary Diseas	August 2012	$2000
Anemia – Pipeline Review, H2 2012 By Global Markets Direct Anemia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Anemia - Pipeline Review, H2 2012'', provides an overview of the Anemia therapeutic pipeline. This report provides information on the therapeutic development for Anemia, complet	August 2012	$2000
Neuropathic Pain – Pipeline Review, H2 2012 By Global Markets Direct Neuropathic Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Neuropathic Pain - Pipeline Review, H2 2012'', provides an overview of the Neuropathic Pain therapeutic pipeline. This report provides information on the therapeutic d	August 2012	$2000
Bladder Cancer – Pipeline Review, H2 2012 By Global Markets Direct Bladder Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Bladder Cancer - Pipeline Review, H2 2012'', provides an overview of the Bladder Cancer therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Hypertension – Pipeline Review, H2 2012 By Global Markets Direct Hypertension – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hypertension - Pipeline Review, H2 2012'', provides an overview of the Hypertension therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Obesity – Pipeline Review, H2 2012 By Global Markets Direct Obesity – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Obesity - Pipeline Review, H2 2012'', provides an overview of the Obesity therapeutic pipeline. This report provides information on the therapeutic development for Obesity, com	August 2012	$2000
Psoriasis – Pipeline Review, H2 2012 By Global Markets Direct Psoriasis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Psoriasis - Pipeline Review, H2 2012'', provides an overview of the Psoriasis therapeutic pipeline. This report provides information on the therapeutic development for Psoria	August 2012	$2000
Cervical Cancer – Pipeline Review, H2 2012 By Global Markets Direct Cervical Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Cervical Cancer - Pipeline Review, H2 2012'', provides an overview of the Cervical Cancer therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Schizophrenia – Pipeline Review, H2 2012 By Global Markets Direct Schizophrenia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Schizophrenia - Pipeline Review, H2 2012'', provides an overview of the Schizophrenia therapeutic pipeline. This report provides information on the therapeutic developmen	August 2012	$2000
Macular Degeneration – Pipeline Review, H2 2012 By Global Markets Direct Macular Degeneration – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Macular Degeneration - Pipeline Review, H2 2012'', provides an overview of the Macular Degeneration therapeutic pipeline. This report provides information on the t	August 2012	$2000
Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H2 2012 By Global Markets Direct Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2012'', provides an overview of the Type 1 Diabetes (Juvenile Diabetes) therapeutic pipeli	August 2012	$2000
HIV-1 Infection – Pipeline Review, H2 2012 By Global Markets Direct HIV-1 Infection – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''HIV-1 Infection - Pipeline Review, H2 2012'', provides an overview of the HIV-1 Infection therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Amyotrophic Lateral Sclerosis – Pipeline Review, H2 2012 By Global Markets Direct Amyotrophic Lateral Sclerosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2012'', provides an overview of the Amyotrophic Lateral Sclerosis therapeutic pipeline. This report pr	August 2012	$2000
Tuberculosis – Pipeline Review, H2 2012 By Global Markets Direct Tuberculosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Tuberculosis - Pipeline Review, H2 2012'', provides an overview of the Tuberculosis therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Influenza A Infections – Pipeline Review, H2 2012 By Global Markets Direct Influenza A Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Influenza A Infections - Pipeline Review, H2 2012'', provides an overview of the Influenza A Infections therapeutic pipeline. This report provides information on	August 2012	$2000
Osteoporosis – Pipeline Review, H2 2012 By Global Markets Direct Osteoporosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Osteoporosis - Pipeline Review, H2 2012'', provides an overview of the Osteoporosis therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Crohn's Disease – Pipeline Review, H2 2012 By Global Markets Direct Crohn''s Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Crohn''s Disease - Pipeline Review, H2 2012'', provides an overview of the Crohn''s Disease therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Osteoarthritis – Pipeline Review, H2 2012 By Global Markets Direct Osteoarthritis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Osteoarthritis - Pipeline Review, H2 2012'', provides an overview of the Osteoarthritis therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Major Depressive Disorder – Pipeline Review, H2 2012 By Global Markets Direct Major Depressive Disorder – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Major Depressive Disorder - Pipeline Review, H2 2012'', provides an overview of the Major Depressive Disorder therapeutic pipeline. This report provides infor	August 2012	$2000
Thrombocytopenia – Pipeline Review, H2 2012 By Global Markets Direct Thrombocytopenia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Thrombocytopenia - Pipeline Review, H2 2012'', provides an overview of the Thrombocytopenia therapeutic pipeline. This report provides information on the therapeutic d	August 2012	$2000
Pneumonia – Pipeline Review, H2 2012 By Global Markets Direct Pneumonia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pneumonia - Pipeline Review, H2 2012'', provides an overview of the Pneumonia therapeutic pipeline. This report provides information on the therapeutic development for Pneumo	August 2012	$2000
Glaucoma – Pipeline Review, H2 2012 By Global Markets Direct Glaucoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Glaucoma - Pipeline Review, H2 2012'', provides an overview of the Glaucoma therapeutic pipeline. This report provides information on the therapeutic development for Glaucoma,	August 2012	$2000
Atopic Dermatitis (Eczema) – Pipeline Review, H2 2012 By Global Markets Direct Atopic Dermatitis (Eczema) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Atopic Dermatitis (Eczema) - Pipeline Review, H2 2012'', provides an overview of the Atopic Dermatitis (Eczema) therapeutic pipeline. This report provides in	August 2012	$2000
Epilepsy – Pipeline Review, H2 2012 By Global Markets Direct Epilepsy – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Epilepsy - Pipeline Review, H2 2012'', provides an overview of the Epilepsy therapeutic pipeline. This report provides information on the therapeutic development for Epilepsy,	August 2012	$2000
Ulcerative Colitis – Pipeline Review, H2 2012 By Global Markets Direct Ulcerative Colitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Ulcerative Colitis - Pipeline Review, H2 2012'', provides an overview of the Ulcerative Colitis therapeutic pipeline. This report provides information on the therape	August 2012	$2000
Atherosclerosis – Pipeline Review, H2 2012 By Global Markets Direct Atherosclerosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Atherosclerosis - Pipeline Review, H2 2012'', provides an overview of the Atherosclerosis therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Systemic Lupus Erythematosus – Pipeline Review, H2 2012 By Global Markets Direct Systemic Lupus Erythematosus – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Systemic Lupus Erythematosus - Pipeline Review, H2 2012'', provides an overview of the Systemic Lupus Erythematosus therapeutic pipeline. This report provi	August 2012	$2000
Allergic Rhinitis – Pipeline Review, H2 2012 By Global Markets Direct Allergic Rhinitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Allergic Rhinitis - Pipeline Review, H2 2012'', provides an overview of the Allergic Rhinitis therapeutic pipeline. This report provides information on the therapeuti	August 2012	$2000
Dyslipidemia – Pipeline Review, H2 2012 By Global Markets Direct Dyslipidemia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Dyslipidemia - Pipeline Review, H2 2012'', provides an overview of the Dyslipidemia therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Acne And Related Disorders – Pipeline Review, H2 2012 By Global Markets Direct Acne And Related Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acne And Related Disorders - Pipeline Review, H2 2012'', provides an overview of the Acne And Related Disorders therapeutic pipeline. This report provides in	August 2012	$2000
Smoking Cessation – Pipeline Review, H2 2012 By Global Markets Direct Smoking Cessation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Smoking Cessation - Pipeline Review, H2 2012'', provides an overview of the Smoking Cessation therapeutic pipeline. This report provides information on the therapeuti	August 2012	$2000
Bipolar Disorder (Manic Depression) – Pipeline Review, H2 2012 By Global Markets Direct Bipolar Disorder (Manic Depression) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Bipolar Disorder (Manic Depression) - Pipeline Review, H2 2012'', provides an overview of the Bipolar Disorder (Manic Depression) therapeutic pipeli	August 2012	$2000
Hemophilia – Pipeline Review, H2 2012 By Global Markets Direct Hemophilia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hemophilia - Pipeline Review, H2 2012'', provides an overview of the Hemophilia therapeutic pipeline. This report provides information on the therapeutic development for Hem	August 2012	$2000
Attention Deficit Hyperactivity Disorder (ADHD) – Pipeline Review, H2 2012 By Global Markets Direct Attention Deficit Hyperactivity Disorder (ADHD) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2012'', provides an overview of the Attention Deficit Hyperactivit	August 2012	$2000
Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H2 2012 By Global Markets Direct Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2012'', provides an overview of the Chronic Kidney Disease (Chronic	August 2012	$2000
Huntington's Disease – Pipeline Review, H2 2012 By Global Markets Direct Huntington''s Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Huntington''s Disease - Pipeline Review, H2 2012'', provides an overview of the Huntington''s Disease therapeutic pipeline. This report provides information on the t	August 2012	$2000
Acute Pain – Pipeline Review, H2 2012 By Global Markets Direct Acute Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acute Pain - Pipeline Review, H2 2012'', provides an overview of the Acute Pain therapeutic pipeline. This report provides information on the therapeutic development for Acu	August 2012	$2000
Female Infertility – Pipeline Review, H2 2012 By Global Markets Direct Female Infertility – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Female Infertility - Pipeline Review, H2 2012'', provides an overview of the Female Infertility therapeutic pipeline. This report provides information on the therape	August 2012	$2000
Migraine – Pipeline Review, H2 2012 By Global Markets Direct Migraine – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Migraine - Pipeline Review, H2 2012'', provides an overview of the Migraine therapeutic pipeline. This report provides information on the therapeutic development for Migraine,	August 2012	$2000
Irritable Bowel Syndrome – Pipeline Review, H2 2012 By Global Markets Direct Irritable Bowel Syndrome – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Irritable Bowel Syndrome - Pipeline Review, H2 2012'', provides an overview of the Irritable Bowel Syndrome therapeutic pipeline. This report provides informat	August 2012	$2000
Acute Ischemic Stroke – Pipeline Review, H2 2012 By Global Markets Direct Acute Ischemic Stroke – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acute Ischemic Stroke - Pipeline Review, H2 2012'', provides an overview of the Acute Ischemic Stroke therapeutic pipeline. This report provides information on th	August 2012	$2000
Atrial Fibrillation – Pipeline Review, H2 2012 By Global Markets Direct Atrial Fibrillation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Atrial Fibrillation - Pipeline Review, H2 2012'', provides an overview of the Atrial Fibrillation therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Duchenne Muscular Dystrophy – Pipeline Review, H2 2012 By Global Markets Direct Duchenne Muscular Dystrophy – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Duchenne Muscular Dystrophy - Pipeline Review, H2 2012'', provides an overview of the Duchenne Muscular Dystrophy therapeutic pipeline. This report provides	August 2012	$2000
Osteoarthritis Pain – Pipeline Review, H2 2012 By Global Markets Direct Osteoarthritis Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Osteoarthritis Pain - Pipeline Review, H2 2012'', provides an overview of the Osteoarthritis Pain therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Hemophilia A – Pipeline Review, H2 2012 By Global Markets Direct Hemophilia A – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hemophilia A - Pipeline Review, H2 2012'', provides an overview of the Hemophilia A therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Acne Vulgaris – Pipeline Review, H2 2012 By Global Markets Direct Acne Vulgaris – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acne Vulgaris - Pipeline Review, H2 2012'', provides an overview of the Acne Vulgaris therapeutic pipeline. This report provides information on the therapeutic developmen	August 2012	$2000
Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) – Pipeline Review, H2 2012 By Global Markets Direct Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) - Pipeline Review, H2 2012'', provides an overvi	August 2012	$2000
Idiopathic Pulmonary Fibrosis – Pipeline Review, H2 2012 By Global Markets Direct Idiopathic Pulmonary Fibrosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2012'', provides an overview of the Idiopathic Pulmonary Fibrosis therapeutic pipeline. This report pr	August 2012	$2000
Erectile Dysfunction – Pipeline Review, H2 2012 By Global Markets Direct Erectile Dysfunction – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Erectile Dysfunction - Pipeline Review, H2 2012'', provides an overview of the Erectile Dysfunction therapeutic pipeline. This report provides information on the t	August 2012	$2000
Reflux Esophagitis (Gastroesophageal Reflux Disease) – Pipeline Review, H2 2012 By Global Markets Direct Reflux Esophagitis (Gastroesophageal Reflux Disease) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Reflux Esophagitis (Gastroesophageal Reflux Disease) - Pipeline Review, H2 2012'', provides an overview of the Reflux Esophagitis (	August 2012	$2000
Non-Alcoholic Steatohepatitis – Pipeline Review, H2 2012 By Global Markets Direct Non-Alcoholic Steatohepatitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2012'', provides an overview of the Non-Alcoholic Steatohepatitis therapeutic pipeline. This report pr	August 2012	$2000
Autism – Pipeline Review, H2 2012 By Global Markets Direct Autism – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Autism - Pipeline Review, H2 2012'', provides an overview of the Autism therapeutic pipeline. This report provides information on the therapeutic development for Autism, complet	August 2012	$2000
Benign Prostatic Hyperplasia – Pipeline Review, H2 2012 By Global Markets Direct Benign Prostatic Hyperplasia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Benign Prostatic Hyperplasia - Pipeline Review, H2 2012'', provides an overview of the Benign Prostatic Hyperplasia therapeutic pipeline. This report provi	August 2012	$2000
Acute Coronary Syndrome – Pipeline Review, H2 2012 By Global Markets Direct Acute Coronary Syndrome – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acute Coronary Syndrome - Pipeline Review, H2 2012'', provides an overview of the Acute Coronary Syndrome therapeutic pipeline. This report provides information	August 2012	$2000
Male Hypogonadism – Pipeline Review, H2 2012 By Global Markets Direct Male Hypogonadism – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Male Hypogonadism - Pipeline Review, H2 2012'', provides an overview of the Male Hypogonadism therapeutic pipeline. This report provides information on the therapeuti	August 2012	$2000
Insomnia – Pipeline Review, H2 2012 By Global Markets Direct Insomnia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Insomnia - Pipeline Review, H2 2012'', provides an overview of the Insomnia therapeutic pipeline. This report provides information on the therapeutic development for Insomnia,	August 2012	$2000
Gouty Arthritis (Gout) – Pipeline Review, H2 2012 By Global Markets Direct Gouty Arthritis (Gout) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Gouty Arthritis (Gout) - Pipeline Review, H2 2012'', provides an overview of the Gouty Arthritis (Gout) therapeutic pipeline. This report provides information on	August 2012	$2000
Fatty Liver Disease – Pipeline Review, H2 2012 By Global Markets Direct Fatty Liver Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Fatty Liver Disease - Pipeline Review, H2 2012'', provides an overview of the Fatty Liver Disease therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Urinary Tract Infections – Pipeline Review, H2 2012 By Global Markets Direct Urinary Tract Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Urinary Tract Infections - Pipeline Review, H2 2012'', provides an overview of the Urinary Tract Infections therapeutic pipeline. This report provides informat	August 2012	$2000
Meningitis – Pipeline Review, H2 2012 By Global Markets Direct Meningitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Meningitis - Pipeline Review, H2 2012'', provides an overview of the Meningitis therapeutic pipeline. This report provides information on the therapeutic development for Men	August 2012	$2000
Bronchitis – Pipeline Review, H2 2012 By Global Markets Direct Bronchitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Bronchitis - Pipeline Review, H2 2012'', provides an overview of the Bronchitis therapeutic pipeline. This report provides information on the therapeutic development for Bro	August 2012	$2000
Fibromyalgia – Pipeline Review, H2 2012 By Global Markets Direct Fibromyalgia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Fibromyalgia - Pipeline Review, H2 2012'', provides an overview of the Fibromyalgia therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Endometriosis – Pipeline Review, H2 2012 By Global Markets Direct Endometriosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Endometriosis - Pipeline Review, H2 2012'', provides an overview of the Endometriosis therapeutic pipeline. This report provides information on the therapeutic developmen	August 2012	$2000
Celiac Disease – Pipeline Review, H2 2012 By Global Markets Direct Celiac Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Celiac Disease - Pipeline Review, H2 2012'', provides an overview of the Celiac Disease therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Urinary Incontinence – Pipeline Review, H2 2012 By Global Markets Direct Urinary Incontinence – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Urinary Incontinence - Pipeline Review, H2 2012'', provides an overview of the Urinary Incontinence therapeutic pipeline. This report provides information on the t	August 2012	$2000
Venous Thromboembolism – Pipeline Review, H2 2012 By Global Markets Direct Venous Thromboembolism – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Venous Thromboembolism - Pipeline Review, H2 2012'', provides an overview of the Venous Thromboembolism therapeutic pipeline. This report provides information on	August 2012	$2000
Periodontal Disease – Pipeline Review, H2 2012 By Global Markets Direct Periodontal Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Periodontal Disease - Pipeline Review, H2 2012'', provides an overview of the Periodontal Disease therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Hemophilia B – Pipeline Review, H2 2012 By Global Markets Direct Hemophilia B – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hemophilia B - Pipeline Review, H2 2012'', provides an overview of the Hemophilia B therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Dysmenorrhea – Pipeline Review, H2 2012 By Global Markets Direct Dysmenorrhea – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Dysmenorrhea - Pipeline Review, H2 2012'', provides an overview of the Dysmenorrhea therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Aspergillosis – Pipeline Review, H2 2012 By Global Markets Direct Aspergillosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Aspergillosis - Pipeline Review, H2 2012'', provides an overview of the Aspergillosis therapeutic pipeline. This report provides information on the therapeutic developmen	August 2012	$2000
Premature Ejaculation – Pipeline Review, H2 2012 By Global Markets Direct Premature Ejaculation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Premature Ejaculation - Pipeline Review, H2 2012'', provides an overview of the Premature Ejaculation therapeutic pipeline. This report provides information on th	August 2012	$2000
Growth Disorders – Pipeline Review, H2 2012 By Global Markets Direct Growth Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Growth Disorders - Pipeline Review, H2 2012'', provides an overview of the Growth Disorders therapeutic pipeline. This report provides information on the therapeutic d	August 2012	$2000
Genital Herpes – Pipeline Review, H2 2012 By Global Markets Direct Genital Herpes – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Genital Herpes - Pipeline Review, H2 2012'', provides an overview of the Genital Herpes therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Herpes Zoster (Shingles) – Pipeline Review, H2 2012 By Global Markets Direct Herpes Zoster (Shingles) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Herpes Zoster (Shingles) - Pipeline Review, H2 2012'', provides an overview of the Herpes Zoster (Shingles) therapeutic pipeline. This report provides informat	August 2012	$2000
Sinusitis – Pipeline Review, H2 2012 By Global Markets Direct Sinusitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Sinusitis - Pipeline Review, H2 2012'', provides an overview of the Sinusitis therapeutic pipeline. This report provides information on the therapeutic development for Sinusi	August 2012	$2000
Otitis Media – Pipeline Review, H2 2012 By Global Markets Direct Otitis Media – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Otitis Media - Pipeline Review, H2 2012'', provides an overview of the Otitis Media therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Rhinitis – Pipeline Review, H2 2012 By Global Markets Direct Rhinitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Rhinitis - Pipeline Review, H2 2012'', provides an overview of the Rhinitis therapeutic pipeline. This report provides information on the therapeutic development for Rhinitis,	August 2012	$2000
Acute Heart Failure – Pipeline Review, H2 2012 By Global Markets Direct Acute Heart Failure – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acute Heart Failure - Pipeline Review, H2 2012'', provides an overview of the Acute Heart Failure therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Lymphoma – Pipeline Review, H2 2012 By Global Markets Direct Lymphoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Lymphoma - Pipeline Review, H2 2012'', provides an overview of the Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Lymphoma,	August 2012	$2500
Pediatric Cancer – Pipeline Review, H2 2012 By Global Markets Direct Pediatric Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pediatric Cancer - Pipeline Review, H2 2012'', provides an overview of the Pediatric Cancer therapeutic pipeline. This report provides information on the therapeutic d	August 2012	$2000
Male Cancer – Pipeline Review, H2 2012 By Global Markets Direct Male Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Male Cancer - Pipeline Review, H2 2012'', provides an overview of the Male Cancer therapeutic pipeline. This report provides information on the therapeutic development for	August 2012	$2500
Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2012 By Global Markets Direct Hematopoietic Stem Cell Transplantation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Hematopoietic Stem Cell Transplantation - Pipeline Review, H2 2012'', provides an overview of the Hematopoietic Stem Cell Transplantation therap	August 2012	$2000
Myelodysplastic Syndrome – Pipeline Review, H2 2012 By Global Markets Direct Myelodysplastic Syndrome – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Myelodysplastic Syndrome - Pipeline Review, H2 2012'', provides an overview of the Myelodysplastic Syndrome therapeutic pipeline. This report provides informat	August 2012	$2500
Transplantation – Pipeline Review, H2 2012 By Global Markets Direct Transplantation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Transplantation - Pipeline Review, H2 2012'', provides an overview of the Transplantation therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2500
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) – Pipeline Review, H2 2012 By Global Markets Direct Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2012'', provides an overview of the	August 2012	$2500
Functional (Non Ulcer) Dyspepsia – Pipeline Review, H2 2012 By Global Markets Direct Functional (Non Ulcer) Dyspepsia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Functional (Non Ulcer) Dyspepsia - Pipeline Review, H2 2012'', provides an overview of the Functional (Non Ulcer) Dyspepsia therapeutic pipeline. This	August 2012	$2000
Lung Adenocarcinoma – Pipeline Review, H2 2012 By Global Markets Direct Lung Adenocarcinoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Lung Adenocarcinoma - Pipeline Review, H2 2012'', provides an overview of the Lung Adenocarcinoma therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Allergies – Pipeline Review, H2 2012 By Global Markets Direct Allergies – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Allergies - Pipeline Review, H2 2012'', provides an overview of the Allergies therapeutic pipeline. This report provides information on the therapeutic development for Allerg	August 2012	$2000
Kidney Disease – Pipeline Review, H2 2012 By Global Markets Direct Kidney Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Kidney Disease - Pipeline Review, H2 2012'', provides an overview of the Kidney Disease therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Skin Inflammation – Pipeline Review, H2 2012 By Global Markets Direct Skin Inflammation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Skin Inflammation - Pipeline Review, H2 2012'', provides an overview of the Skin Inflammation therapeutic pipeline. This report provides information on the therapeuti	August 2012	$2000
Mycoses – Pipeline Review, H2 2012 By Global Markets Direct Mycoses – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Mycoses - Pipeline Review, H2 2012'', provides an overview of the Mycoses therapeutic pipeline. This report provides information on the therapeutic development for Mycoses, com	August 2012	$2000
Cognitive Impairment – Pipeline Review, H2 2012 By Global Markets Direct Cognitive Impairment – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Cognitive Impairment - Pipeline Review, H2 2012'', provides an overview of the Cognitive Impairment therapeutic pipeline. This report provides information on the t	August 2012	$2000
Bone Metastasis – Pipeline Review, H2 2012 By Global Markets Direct Bone Metastasis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Bone Metastasis - Pipeline Review, H2 2012'', provides an overview of the Bone Metastasis therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Movement Disorders – Pipeline Review, H2 2012 By Global Markets Direct Movement Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Movement Disorders - Pipeline Review, H2 2012'', provides an overview of the Movement Disorders therapeutic pipeline. This report provides information on the therape	August 2012	$2000
Trypanosomiasis – Pipeline Review, H2 2012 By Global Markets Direct Trypanosomiasis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Trypanosomiasis - Pipeline Review, H2 2012'', provides an overview of the Trypanosomiasis therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Conjunctivitis – Pipeline Review, H2 2012 By Global Markets Direct Conjunctivitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Conjunctivitis - Pipeline Review, H2 2012'', provides an overview of the Conjunctivitis therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Metastatic Prostate Cancer – Pipeline Review, H2 2012 By Global Markets Direct Metastatic Prostate Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Metastatic Prostate Cancer - Pipeline Review, H2 2012'', provides an overview of the Metastatic Prostate Cancer therapeutic pipeline. This report provides in	August 2012	$2000
Upper Respiratory Tract Disorders – Pipeline Review, H2 2012 By Global Markets Direct Upper Respiratory Tract Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Upper Respiratory Tract Disorders - Pipeline Review, H2 2012'', provides an overview of the Upper Respiratory Tract Disorders therapeutic pipeline. Th	August 2012	$2000
Pseudomonas Aeruginosa Infections – Pipeline Review, H2 2012 By Global Markets Direct Pseudomonas Aeruginosa Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pseudomonas Aeruginosa Infections - Pipeline Review, H2 2012'', provides an overview of the Pseudomonas Aeruginosa Infections therapeutic pipeline. Th	August 2012	$2000
Other Central Nervous System Disorders – Pipeline Review, H2 2012 By Global Markets Direct Other Central Nervous System Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Central Nervous System Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Central Nervous System Disorders therapeut	August 2012	$2000
Contraceptives – Pipeline Review, H2 2012 By Global Markets Direct Contraceptives – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Contraceptives - Pipeline Review, H2 2012'', provides an overview of the Contraceptives therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Encephalitis – Pipeline Review, H2 2012 By Global Markets Direct Encephalitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Encephalitis - Pipeline Review, H2 2012'', provides an overview of the Encephalitis therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Oral Mucositis – Pipeline Review, H2 2012 By Global Markets Direct Oral Mucositis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Oral Mucositis - Pipeline Review, H2 2012'', provides an overview of the Oral Mucositis therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Pyelonephritis – Pipeline Review, H2 2012 By Global Markets Direct Pyelonephritis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pyelonephritis - Pipeline Review, H2 2012'', provides an overview of the Pyelonephritis therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Bordetella Pertussis Infections – Pipeline Review, H2 2012 By Global Markets Direct Bordetella Pertussis Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Bordetella Pertussis Infections - Pipeline Review, H2 2012'', provides an overview of the Bordetella Pertussis Infections therapeutic pipeline. This rep	August 2012	$2000
Scar – Pipeline Review, H2 2012 By Global Markets Direct Scar – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Scar - Pipeline Review, H2 2012'', provides an overview of the Scar therapeutic pipeline. This report provides information on the therapeutic development for Scar, complete with l	August 2012	$2000
Spasticity – Pipeline Review, H2 2012 By Global Markets Direct Spasticity – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Spasticity - Pipeline Review, H2 2012'', provides an overview of the Spasticity therapeutic pipeline. This report provides information on the therapeutic development for Spa	August 2012	$2000
Skin And Skin Structure Infections (SSSI) – Pipeline Review, H2 2012 By Global Markets Direct Skin And Skin Structure Infections (SSSI) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Skin And Skin Structure Infections (SSSI) - Pipeline Review, H2 2012'', provides an overview of the Skin And Skin Structure Infections (SSSI)	August 2012	$2000
Dysautonomia (Autonomic Dysfunction) – Pipeline Review, H2 2012 By Global Markets Direct Dysautonomia (Autonomic Dysfunction) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Dysautonomia (Autonomic Dysfunction) - Pipeline Review, H2 2012'', provides an overview of the Dysautonomia (Autonomic Dysfunction) therapeutic pip	August 2012	$2000
Biliary Cirrhosis – Pipeline Review, H2 2012 By Global Markets Direct Biliary Cirrhosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Biliary Cirrhosis - Pipeline Review, H2 2012'', provides an overview of the Biliary Cirrhosis therapeutic pipeline. This report provides information on the therapeuti	August 2012	$2000
High Triglyceridemia – Pipeline Review, H2 2012 By Global Markets Direct High Triglyceridemia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''High Triglyceridemia - Pipeline Review, H2 2012'', provides an overview of the High Triglyceridemia therapeutic pipeline. This report provides information on the t	August 2012	$2000
Other Gastrointestinal Disorders – Pipeline Review, H2 2012 By Global Markets Direct Other Gastrointestinal Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Gastrointestinal Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Gastrointestinal Disorders therapeutic pipeline. This	August 2012	$2000
Other Toxic Disorders – Pipeline Review, H2 2012 By Global Markets Direct Other Toxic Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Toxic Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Toxic Disorders therapeutic pipeline. This report provides information on th	August 2012	$2000
Other Pain Disorders – Pipeline Review, H2 2012 By Global Markets Direct Other Pain Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Pain Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Pain Disorders therapeutic pipeline. This report provides information on the t	August 2012	$2000
Anaplastic Thyroid Cancer – Pipeline Review, H2 2012 By Global Markets Direct Anaplastic Thyroid Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Anaplastic Thyroid Cancer - Pipeline Review, H2 2012'', provides an overview of the Anaplastic Thyroid Cancer therapeutic pipeline. This report provides infor	August 2012	$2000
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) – Pipeline Review, H2 2012 By Global Markets Direct Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Review, H2 2012'', provides a	August 2012	$2000
Eosinophilic Esophagitis – Pipeline Review, H2 2012 By Global Markets Direct Eosinophilic Esophagitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Eosinophilic Esophagitis - Pipeline Review, H2 2012'', provides an overview of the Eosinophilic Esophagitis therapeutic pipeline. This report provides informat	August 2012	$2000
Ovarian Disease – Pipeline Review, H2 2012 By Global Markets Direct Ovarian Disease – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Ovarian Disease - Pipeline Review, H2 2012'', provides an overview of the Ovarian Disease therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Dermatophytosis – Pipeline Review, H2 2012 By Global Markets Direct Dermatophytosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Dermatophytosis - Pipeline Review, H2 2012'', provides an overview of the Dermatophytosis therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Labor And Delivery – Pipeline Review, H2 2012 By Global Markets Direct Labor And Delivery – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Labor And Delivery - Pipeline Review, H2 2012'', provides an overview of the Labor And Delivery therapeutic pipeline. This report provides information on the therape	August 2012	$2000
Other Respiratory Disorders – Pipeline Review, H2 2012 By Global Markets Direct Other Respiratory Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Respiratory Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Respiratory Disorders therapeutic pipeline. This report provides	August 2012	$2000
Abortion – Pipeline Review, H2 2012 By Global Markets Direct Abortion – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Abortion - Pipeline Review, H2 2012'', provides an overview of the Abortion therapeutic pipeline. This report provides information on the therapeutic development for Abortion,	August 2012	$2000
Polycystic Ovarian Syndrome – Pipeline Review, H2 2012 By Global Markets Direct Polycystic Ovarian Syndrome – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Polycystic Ovarian Syndrome - Pipeline Review, H2 2012'', provides an overview of the Polycystic Ovarian Syndrome therapeutic pipeline. This report provides	August 2012	$2000
Pancreatic Diseases – Pipeline Review, H2 2012 By Global Markets Direct Pancreatic Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pancreatic Diseases - Pipeline Review, H2 2012'', provides an overview of the Pancreatic Diseases therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Non-Rhabdomyosarcoma – Pipeline Review, H2 2012 By Global Markets Direct Non-Rhabdomyosarcoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Non-Rhabdomyosarcoma - Pipeline Review, H2 2012'', provides an overview of the Non-Rhabdomyosarcoma therapeutic pipeline. This report provides information on the t	August 2012	$2000
Chikungunya – Pipeline Review, H2 2012 By Global Markets Direct Chikungunya – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Chikungunya - Pipeline Review, H2 2012'', provides an overview of the Chikungunya therapeutic pipeline. This report provides information on the therapeutic development for	August 2012	$2000
Other Bacterial Infections – Pipeline Review, H2 2012 By Global Markets Direct Other Bacterial Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Bacterial Infections - Pipeline Review, H2 2012'', provides an overview of the Other Bacterial Infections therapeutic pipeline. This report provides in	August 2012	$2000
Complicated Skin And Skin Structure Infections (cSSSI) – Pipeline Review, H2 2012 By Global Markets Direct Complicated Skin And Skin Structure Infections (cSSSI) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Complicated Skin And Skin Structure Infections (cSSSI) - Pipeline Review, H2 2012'', provides an overview of the Complicated Skin	August 2012	$2000
Chronic Bronchitis – Pipeline Review, H2 2012 By Global Markets Direct Chronic Bronchitis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Chronic Bronchitis - Pipeline Review, H2 2012'', provides an overview of the Chronic Bronchitis therapeutic pipeline. This report provides information on the therape	August 2012	$2000
Autoimmune Disorders – Pipeline Review, H2 2012 By Global Markets Direct Autoimmune Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Autoimmune Disorders - Pipeline Review, H2 2012'', provides an overview of the Autoimmune Disorders therapeutic pipeline. This report provides information on the t	August 2012	$2500
Angiosarcoma – Pipeline Review, H2 2012 By Global Markets Direct Angiosarcoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Angiosarcoma - Pipeline Review, H2 2012'', provides an overview of the Angiosarcoma therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
HIV / AIDS – Pipeline Review, H2 2012 By Global Markets Direct HIV / AIDS – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''HIV / AIDS - Pipeline Review, H2 2012'', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information on the therapeutic development for HIV	August 2012	$2500
Astrocytoma – Pipeline Review, H2 2012 By Global Markets Direct Astrocytoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Astrocytoma - Pipeline Review, H2 2012'', provides an overview of the Astrocytoma therapeutic pipeline. This report provides information on the therapeutic development for	August 2012	$2500
Orthomyxoviridae Infections – Pipeline Review, H2 2012 By Global Markets Direct Orthomyxoviridae Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Orthomyxoviridae Infections - Pipeline Review, H2 2012'', provides an overview of the Orthomyxoviridae Infections therapeutic pipeline. This report provides	August 2012	$2500
Metastatic Colorectal Cancer – Pipeline Review, H2 2012 By Global Markets Direct Metastatic Colorectal Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Metastatic Colorectal Cancer - Pipeline Review, H2 2012'', provides an overview of the Metastatic Colorectal Cancer therapeutic pipeline. This report provi	August 2012	$2000
Brain Cancer – Pipeline Review, H2 2012 By Global Markets Direct Brain Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Brain Cancer - Pipeline Review, H2 2012'', provides an overview of the Brain Cancer therapeutic pipeline. This report provides information on the therapeutic development f	August 2012	$2000
Mycobacterium Infections – Pipeline Review, H2 2012 By Global Markets Direct Mycobacterium Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Mycobacterium Infections - Pipeline Review, H2 2012'', provides an overview of the Mycobacterium Infections therapeutic pipeline. This report provides informat	August 2012	$2000
Fungal Infections – Pipeline Review, H2 2012 By Global Markets Direct Fungal Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Fungal Infections - Pipeline Review, H2 2012'', provides an overview of the Fungal Infections therapeutic pipeline. This report provides information on the therapeuti	August 2012	$2000
Adenocarcinoma – Pipeline Review, H2 2012 By Global Markets Direct Adenocarcinoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Adenocarcinoma - Pipeline Review, H2 2012'', provides an overview of the Adenocarcinoma therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Swine Influenza – Pipeline Review, H2 2012 By Global Markets Direct Swine Influenza – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Swine Influenza - Pipeline Review, H2 2012'', provides an overview of the Swine Influenza therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Brain Metastasis – Pipeline Review, H2 2012 By Global Markets Direct Brain Metastasis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Brain Metastasis - Pipeline Review, H2 2012'', provides an overview of the Brain Metastasis therapeutic pipeline. This report provides information on the therapeutic d	August 2012	$2000
Metastatic Renal Cell Carcinoma – Pipeline Review, H2 2012 By Global Markets Direct Metastatic Renal Cell Carcinoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Metastatic Renal Cell Carcinoma - Pipeline Review, H2 2012'', provides an overview of the Metastatic Renal Cell Carcinoma therapeutic pipeline. This rep	August 2012	$2000
Leukocyte Disorders (White Blood Cell Disorders) – Pipeline Review, H2 2012 By Global Markets Direct Leukocyte Disorders (White Blood Cell Disorders) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Leukocyte Disorders (White Blood Cell Disorders) - Pipeline Review, H2 2012'', provides an overview of the Leukocyte Disorders (White B	August 2012	$2000
Nausea – Pipeline Review, H2 2012 By Global Markets Direct Nausea – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Nausea - Pipeline Review, H2 2012'', provides an overview of the Nausea therapeutic pipeline. This report provides information on the therapeutic development for Nausea, complet	August 2012	$2000
Inflammatory Pain – Pipeline Review, H2 2012 By Global Markets Direct Inflammatory Pain – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Inflammatory Pain - Pipeline Review, H2 2012'', provides an overview of the Inflammatory Pain therapeutic pipeline. This report provides information on the therapeuti	August 2012	$2000
Streptococcal Infections – Pipeline Review, H2 2012 By Global Markets Direct Streptococcal Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Streptococcal Infections - Pipeline Review, H2 2012'', provides an overview of the Streptococcal Infections therapeutic pipeline. This report provides informat	August 2012	$2000
Plaque Psoriasis (Psoriasis Vulgaris) – Pipeline Review, H2 2012 By Global Markets Direct Plaque Psoriasis (Psoriasis Vulgaris) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2012'', provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) therapeutic	August 2012	$2000
Pollen Allergy – Pipeline Review, H2 2012 By Global Markets Direct Pollen Allergy – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pollen Allergy - Pipeline Review, H2 2012'', provides an overview of the Pollen Allergy therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Other Musculoskeletal Disorders – Pipeline Review, H2 2012 By Global Markets Direct Other Musculoskeletal Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Musculoskeletal Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Musculoskeletal Disorders therapeutic pipeline. This rep	August 2012	$2000
Infections Caused By Picornaviridae – Pipeline Review, H2 2012 By Global Markets Direct Infections Caused By Picornaviridae – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Infections Caused By Picornaviridae - Pipeline Review, H2 2012'', provides an overview of the Infections Caused By Picornaviridae therapeutic pipeli	August 2012	$2000
Inherited Metabolic Disorders – Pipeline Review, H2 2012 By Global Markets Direct Inherited Metabolic Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Inherited Metabolic Disorders - Pipeline Review, H2 2012'', provides an overview of the Inherited Metabolic Disorders therapeutic pipeline. This report pr	August 2012	$2000
Oral Cancer – Pipeline Review, H2 2012 By Global Markets Direct Oral Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Oral Cancer - Pipeline Review, H2 2012'', provides an overview of the Oral Cancer therapeutic pipeline. This report provides information on the therapeutic development for	August 2012	$2000
Lung Infections – Pipeline Review, H2 2012 By Global Markets Direct Lung Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Lung Infections - Pipeline Review, H2 2012'', provides an overview of the Lung Infections therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Liver Transplantation – Pipeline Review, H2 2012 By Global Markets Direct Liver Transplantation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Liver Transplantation - Pipeline Review, H2 2012'', provides an overview of the Liver Transplantation therapeutic pipeline. This report provides information on th	August 2012	$2000
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) – Pipeline Review, H2 2012 By Global Markets Direct Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2012'', provides an overview of the Fami	August 2012	$2000
Spinal Muscular Atrophy (SMA) – Pipeline Review, H2 2012 By Global Markets Direct Spinal Muscular Atrophy (SMA) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Spinal Muscular Atrophy (SMA) - Pipeline Review, H2 2012'', provides an overview of the Spinal Muscular Atrophy (SMA) therapeutic pipeline. This report pr	August 2012	$2000
Pulmonary Hypertension – Pipeline Review, H2 2012 By Global Markets Direct Pulmonary Hypertension – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pulmonary Hypertension - Pipeline Review, H2 2012'', provides an overview of the Pulmonary Hypertension therapeutic pipeline. This report provides information on	August 2012	$2000
Varicella Zoster (HHV-3) Infections – Pipeline Review, H2 2012 By Global Markets Direct Varicella Zoster (HHV-3) Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Varicella Zoster (HHV-3) Infections - Pipeline Review, H2 2012'', provides an overview of the Varicella Zoster (HHV-3) Infections therapeutic pipeli	August 2012	$2000
Enterococcus Faecium Infections – Pipeline Review, H2 2012 By Global Markets Direct Enterococcus Faecium Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Enterococcus Faecium Infections - Pipeline Review, H2 2012'', provides an overview of the Enterococcus Faecium Infections therapeutic pipeline. This rep	August 2012	$2000
Measles – Pipeline Review, H2 2012 By Global Markets Direct Measles – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Measles - Pipeline Review, H2 2012'', provides an overview of the Measles therapeutic pipeline. This report provides information on the therapeutic development for Measles, com	August 2012	$2000
Lip Cancer – Pipeline Review, H2 2012 By Global Markets Direct Lip Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Lip Cancer - Pipeline Review, H2 2012'', provides an overview of the Lip Cancer therapeutic pipeline. This report provides information on the therapeutic development for Lip	August 2012	$2000
Other Immunological Disorders – Pipeline Review, H2 2012 By Global Markets Direct Other Immunological Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Immunological Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Immunological Disorders therapeutic pipeline. This report pr	August 2012	$2000
Other Psychiatric Disorders – Pipeline Review, H2 2012 By Global Markets Direct Other Psychiatric Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Psychiatric Disorders - Pipeline Review, H2 2012'', provides an overview of the Other Psychiatric Disorders therapeutic pipeline. This report provides	August 2012	$2000
Idiopathic (Essential) Hypertension – Pipeline Review, H2 2012 By Global Markets Direct Idiopathic (Essential) Hypertension – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Idiopathic (Essential) Hypertension - Pipeline Review, H2 2012'', provides an overview of the Idiopathic (Essential) Hypertension therapeutic pipeli	August 2012	$2000
Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy – Pipeline Review, H2 2012 By Global Markets Direct Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy - Pipeline Review, H2 2012'', provides a	August 2012	$2000
Oral Cavity (Mouth) Cancer – Pipeline Review, H2 2012 By Global Markets Direct Oral Cavity (Mouth) Cancer – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Oral Cavity (Mouth) Cancer - Pipeline Review, H2 2012'', provides an overview of the Oral Cavity (Mouth) Cancer therapeutic pipeline. This report provides in	August 2012	$2000
Drug Addiction – Pipeline Review, H2 2012 By Global Markets Direct Drug Addiction – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Drug Addiction - Pipeline Review, H2 2012'', provides an overview of the Drug Addiction therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Other Viral Infections – Pipeline Review, H2 2012 By Global Markets Direct Other Viral Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Other Viral Infections - Pipeline Review, H2 2012'', provides an overview of the Other Viral Infections therapeutic pipeline. This report provides information on	August 2012	$2000
Inflammatory Skin Diseases – Pipeline Review, H2 2012 By Global Markets Direct Inflammatory Skin Diseases – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Inflammatory Skin Diseases - Pipeline Review, H2 2012'', provides an overview of the Inflammatory Skin Diseases therapeutic pipeline. This report provides in	August 2012	$2000
Bone Marrow Transplantation – Pipeline Review, H2 2012 By Global Markets Direct Bone Marrow Transplantation – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Bone Marrow Transplantation - Pipeline Review, H2 2012'', provides an overview of the Bone Marrow Transplantation therapeutic pipeline. This report provides	August 2012	$2000
Paralysis – Pipeline Review, H2 2012 By Global Markets Direct Paralysis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Paralysis - Pipeline Review, H2 2012'', provides an overview of the Paralysis therapeutic pipeline. This report provides information on the therapeutic development for Paraly	August 2012	$2000
Clostridium Botulinum Infections – Pipeline Review, H2 2012 By Global Markets Direct Clostridium Botulinum Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Clostridium Botulinum Infections - Pipeline Review, H2 2012'', provides an overview of the Clostridium Botulinum Infections therapeutic pipeline. This	August 2012	$2000
Psychosis – Pipeline Review, H2 2012 By Global Markets Direct Psychosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Psychosis - Pipeline Review, H2 2012'', provides an overview of the Psychosis therapeutic pipeline. This report provides information on the therapeutic development for Psycho	August 2012	$2000
Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H2 2012 By Global Markets Direct Non Alcoholic Fatty Liver Disease (NAFLD) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Non Alcoholic Fatty Liver Disease (NAFLD) - Pipeline Review, H2 2012'', provides an overview of the Non Alcoholic Fatty Liver Disease (NAFLD)	August 2012	$2000
Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade's Disease) – Pipeline Review, H2 2012 By Global Markets Direct Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade''s Disease) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Familial Amyloid Polyneuropathy (Transthyretin Amyloidosis, Corino de Andrade''s Disease) - Pip	August 2012	$2000
Febrile Neutropenia – Pipeline Review, H2 2012 By Global Markets Direct Febrile Neutropenia – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Febrile Neutropenia - Pipeline Review, H2 2012'', provides an overview of the Febrile Neutropenia therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Peanut Allergy – Pipeline Review, H2 2012 By Global Markets Direct Peanut Allergy – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Peanut Allergy - Pipeline Review, H2 2012'', provides an overview of the Peanut Allergy therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Pleural Effusion – Pipeline Review, H2 2012 By Global Markets Direct Pleural Effusion – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Pleural Effusion - Pipeline Review, H2 2012'', provides an overview of the Pleural Effusion therapeutic pipeline. This report provides information on the therapeutic d	August 2012	$2000
Cutaneous Lupus Erythematosus – Pipeline Review, H2 2012 By Global Markets Direct Cutaneous Lupus Erythematosus – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Cutaneous Lupus Erythematosus - Pipeline Review, H2 2012'', provides an overview of the Cutaneous Lupus Erythematosus therapeutic pipeline. This report pr	August 2012	$2000
Primary Progressive Multiple Sclerosis (PPMS) – Pipeline Review, H2 2012 By Global Markets Direct Primary Progressive Multiple Sclerosis (PPMS) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Primary Progressive Multiple Sclerosis (PPMS) - Pipeline Review, H2 2012'', provides an overview of the Primary Progressive Multiple Scler	August 2012	$2000
Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) – Pipeline Review, H2 2012 By Global Markets Direct Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) - Pipeline Review, H2 2012'', provides an overview of the Mucopolysaccharidosi	August 2012	$2000
Kidney Fibrosis – Pipeline Review, H2 2012 By Global Markets Direct Kidney Fibrosis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Kidney Fibrosis - Pipeline Review, H2 2012'', provides an overview of the Kidney Fibrosis therapeutic pipeline. This report provides information on the therapeutic deve	August 2012	$2000
Chronic Lymphoblastic Lymphoma – Pipeline Review, H2 2012 By Global Markets Direct Chronic Lymphoblastic Lymphoma – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Chronic Lymphoblastic Lymphoma - Pipeline Review, H2 2012'', provides an overview of the Chronic Lymphoblastic Lymphoma therapeutic pipeline. This report	August 2012	$2000
Rotavirus Infections – Pipeline Review, H2 2012 By Global Markets Direct Rotavirus Infections – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Rotavirus Infections - Pipeline Review, H2 2012'', provides an overview of the Rotavirus Infections therapeutic pipeline. This report provides information on the t	August 2012	$2000
Rheumatic Disorders – Pipeline Review, H2 2012 By Global Markets Direct Rheumatic Disorders – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Rheumatic Disorders - Pipeline Review, H2 2012'', provides an overview of the Rheumatic Disorders therapeutic pipeline. This report provides information on the ther	August 2012	$2000
Post Operative Nausea And Vomiting – Pipeline Review, H2 2012 By Global Markets Direct Post Operative Nausea And Vomiting – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Post Operative Nausea And Vomiting - Pipeline Review, H2 2012'', provides an overview of the Post Operative Nausea And Vomiting therapeutic pipeline.	August 2012	$2000
Optic Neuritis – Pipeline Review, H2 2012 By Global Markets Direct Optic Neuritis – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Optic Neuritis - Pipeline Review, H2 2012'', provides an overview of the Optic Neuritis therapeutic pipeline. This report provides information on the therapeutic develop	August 2012	$2000
Premenstrual Dysphoric Disorder (PMDD) – Pipeline Review, H2 2012 By Global Markets Direct Premenstrual Dysphoric Disorder (PMDD) – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Premenstrual Dysphoric Disorder (PMDD) - Pipeline Review, H2 2012'', provides an overview of the Premenstrual Dysphoric Disorder (PMDD) therapeut	August 2012	$2000
Down Syndrome – Pipeline Review, H2 2012 By Global Markets Direct Down Syndrome – Pipeline Review, H2 2012 Summary Global Markets Direct’s, ''Down Syndrome - Pipeline Review, H2 2012'', provides an overview of the Down Syndrome therapeutic pipeline. This report provides information on the therapeutic developmen	August 2012	$2000
Consumer Lifestyles in Chile By Euromonitor International Household disposable incomes have been growing in Chile and exceed Latin American averages. Yet, the high income gap between the rich and the poor remains: poor and extremely poor people still account for more than half the population. Trends include	August 2012	$1900
Consumer Lifestyles in Qatar By Euromonitor International Wealthy, ambitious Qatari consumers live in a country of contradictions. A minority population of nationals live in comfort, backed up by a prosperous group of professional expatriates and a large population of expatriate labourers earning very low w	August 2012	$1900
Global Nostalgia Marketing By Euromonitor International In an uncertain economic climate, consumers view the past through rose-tinted glasses and are ready to spend on any product or service that can help them recreate the feelings of warmth and security they felt during happier times. At the same time, f	August 2012	$2600
Travel and Tourism in Bulgaria By Euromonitor International The travel and tourism industry in Bulgaria recorded impressive growth rates in 2011 despite the slow recovery of the Bulgarian economy and the turmoil in the EU, caused by the Greek sovereign debt crisis. Amongst the main reasons for the good perfor	August 2012	$1900
Global Natural Colors and Flavors Market by Types, Applications and Geography: Forecasts up to 2017 By MarketsandMarkets Natural colors and flavors are type of food additives that are added to food and beverages to make products more appealing and tasty. Its use in food and beverage industry is increasing since last decade. Rising demand for natural foods and consum...	August 2012	$4650
Android Device Database: Activations by Vendor, Form Factor, Device Model and Region By Signals and Systems Telecom SynopsisCovering over 600 tablets and smartphones from 63 vendors, this XLS database tracks Android activations by individual device model, form factor, vendor and region. The target audience for this report includes ...	August 2012	$2500
Green Cleaning Products in the U.S. By Packaged Facts Continued consumer interest in and understanding of more sustainable lifestyles has driven the U.S. market for green (eco-friendly) cleaning products—including household surface cleaners and laundry products—to total retail...	August 2012	$3000
Personal Accident and Health Insurance in Iran, Key Trends and Opportunities to 2016 By Timetric SynopsisThe report provides in depth market analysis, information and insights into the Iranian personal accident and health insurance market, including:The Iranian life insurance market’s growth pros...	August 2012	$1950
Personal Accident and Health Insurance in Pakistan, Key Trends and Opportunities to 2016 By Timetric SynopsisThe report provides in depth market analysis, information and insights into the Pakistan personal accident and health insurance market, including:The Pakistan life insurance market’s growth prospec...	August 2012	$1950
Personal Accident and Health Insurance in Belgium, Key Trends and Opportunities to 2016 By Timetric SynopsisThe report provides in depth market analysis, information and insights into the Belgian personal accident and health insurance market, including:The Belgian personal accident and health insurance market&...	August 2012	$1950
Non-Life Insurance in Egypt, Key Trends and Opportunities to 2016 By Timetric SynopsisThe report provides in depth market analysis, information and insights into the Egyptian non-life insurance market, including:The Egyptian non-life insurance market’s growth prospects by non-life i...	August 2012	$1950
Reinsurance in Egypt, Key Trends and Opportunities to 2016 By Timetric SynopsisThe report provides in depth market analysis, information and insights into the Egyptian reinsurance market, including:The Egyptian reinsurance market’s growth prospects by reinsurance categories	August 2012	$1950
Advances in Delivery to the Central Nervous System By Business Insights The blood-brain barrier (BBB) and the blood cerebrospinal fluid barrier (BCSFB) exist to protect the brain, stringently regulating substances into and out of the brain. This report examines the ways in which these natural barriers may be overcome ...	August 2012	$2875
Drug Discovery in Rare Diseases By Datamonitor In comparison with major diseases, the targeting of rare diseases poses many different challenges, necessitating consideration of bespoke R&D strategies for drug discovery efforts to be successful. This report examines the role that low diseas...	August 2012	$3800
Spine Surgery Devices Market Forecasts to 2017 - (Fusion, Non-fusion, Artificial discs, Nucleus replacement, Spinal decompression, Vertebral Compression Fractures treatment, Kyphoplasty, Spine stimulators, and Spine biologics) - Global Trends & Competitive Analysis By MarketsandMarkets Spine surgery devices market is considered as a very important and lucrative sub segment of orthopedic industry. The global spine surgery devices market is estimated at $11,554 million in 2012 and is poised to grow at a CAGR of 5.1% to reach $14,8...	August 2012	$4650
Ireland Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018 By Global Markets Direct Ireland Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, “Ireland Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market da	August 2012	$2500
Greece Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018 By Global Markets Direct Greece Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, “Greece Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market data	August 2012	$2500
Hungary Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018 By Global Markets Direct Hungary Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, “Hungary Cardiovascular Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market da	August 2012	$2500
Ireland Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018 By Global Markets Direct Ireland Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, “Ireland Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on th	August 2012	$2500
Greece Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018 By Global Markets Direct Greece Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, “Greece Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on the	August 2012	$2500
Hungary Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018 By Global Markets Direct Hungary Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, “Hungary Orthopedic Devices Investment Opportunities, Analysis and Forecasts to 2018” provides key market data on th	August 2012	$2500
United Arab Emirates Orthopedic Devices Market Investment Opportunities, Analysis and Forecasts to 2018 By Global Markets Direct United Arab Emirates Orthopedic Devices Market Investment Opportunities, Analysis and Forecasts to 2018 Summary Global Markets Direct’s new report, “United Arab Emirates Orthopedic Devices Market Investment Opportunities, Analysis and Forecasts	August 2012	$2500
Research on China’s Bicycle Hub Market from 2012 to 2016 By Huidian Research There are nearly 30 bicycle hub enterprises in China and a number of international brands presence in the domestic market, mainly are Quando, Joy and Shinano. In 2011, the sales revenue of China’s bicycle hub industry reached CNY 4.197 billion, year-	August 2012	$1500
Argentina Petrochemicals Industry Outlook to 2016 - Market Size, Company Share, Price Trends and Capacity Forecasts By GlobalData Argentina Petrochemicals Industry Outlook to 2016 - Market Size, Company Share, Price Trends and Capacity Forecasts Summary GlobalData’s report, “Argentina Petrochemicals Industry Outlook to 2016 - Market Size, Company Share, Price Trends and C	August 2012	$2500
Thailand Petrochemicals Industry Outlook to 2016 - Market Size, Company Share, Price Trends and Capacity Forecasts By GlobalData Thailand Petrochemicals Industry Outlook to 2016 - Market Size, Company Share, Price Trends and Capacity Forecasts Summary GlobalData’s report, “Thailand Petrochemicals Industry Outlook to 2016 - Market Size, Company Share, Price Trends and Cap	August 2012	$2500
Europe Ethylbenzene Industry Outlook to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants By GlobalData Europe Ethylbenzene Industry Outlook to 2016 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalData’s report, Europe Ethylbenzene Industry Outlook to 2016 - Market Size, Company Share,	August 2012	$3500
Benin Power Market Outlook to 2030 - Business Propensity Indicator (BPI), Market Trends, Regulations and Competitive Landscape By GlobalData Benin Power Market Outlook to 2030 - Business Propensity Indicator (BPI), Market Trends, Regulations and Competitive Landscape Summary This report examines the country’s power market structure and provides historical and forecast numbers for ge	August 2012	$1500
Côte d’Ivoire Power Market Outlook to 2030 - Business Propensity Indicator (BPI), Market Trends, Regulation and Competitive Landscape By GlobalData Côte d’Ivoire Power Market Outlook to 2030 - Business Propensity Indicator (BPI), Market Trends, Regulation and Competitive Landscape Summary This report examines the country’s power market structure and provides historical and forecast numbers	August 2012	$1500
Nigeria Power Market Outlook to 2030: Business Propensity Indicator (BPI), Market Trends, Regulations and Competitive Landscape By GlobalData Nigeria Power Market Outlook to 2030: Business Propensity Indicator (BPI), Market Trends, Regulations and Competitive Landscape Summary This report examines the country’s power market structure and provides historical and forecast numbers for g	August 2012	$1500
Mexico Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape By GlobalData Mexico Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape Summary This report gives detailed information on the Mexico power market. It examines the country’s power market structure and provides historical and f	August 2012	$1500
Thermal Power in Australia, Market Outlook to 2020, 2012 Update – Capacity, Generation, Regulations, Power Plants, Companies By GlobalData Thermal Power in Australia, Market Outlook to 2020, 2012 Update – Capacity, Generation, Regulations, Power Plants, Companies Summary This report gives a view of the country’s thermal energy market and provides forecasts to 2020. This report inc	August 2012	$2500
Bangladesh Oil Markets, 2012 By GlobalData Bangladesh Oil Markets, 2012 Summary This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Bangladesh. It details the m	August 2012	$2500
Papua New Guinea Gas Markets, 2012 By GlobalData Papua New Guinea Gas Markets, 2012 Summary This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Papua New Guinea. It d	August 2012	$2500
Australia Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData Australia Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "Australia Silver Mining Market Overview and Forecast to 2020: Trends,	August 2012	$1500
Mexico Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData Mexico Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "Mexico Silver Mining Market Overview and Forecast to 2020: Trends, Fisca	August 2012	$1500
United States Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData United States Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "United States Silver Mining Market Overview and Forecast to 2020:	August 2012	$1500
Thermal Power in China, Market Outlook to 2020, 2012 Update – Capacity, Generation, Regulations, Power Plants, Companies By GlobalData Thermal Power in China, Market Outlook to 2020, 2012 Update – Capacity, Generation, Regulations, Power Plants, Companies Summary This report gives a view of the country’s thermal energy market and provides forecasts to 2020. This report include	August 2012	$2500
Chile Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData Chile Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "Chile Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal	August 2012	$1500
China Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData China Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "China Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal	August 2012	$1500
Russia Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData Russia Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "Russia Silver Mining Market Overview and Forecast to 2020: Trends, Fisca	August 2012	$1500
Butadiene Asia-Pacific Market to 2020- Polybutadiene, Styrene Butadiene Rubber (SBR) and Acrylonitrile Butadiene Styrene (ABS) to Fuel Demand By GBI Research Butadiene Asia-Pacific Market to 2020- Polybutadiene, Styrene Butadiene Rubber (SBR) and Acrylonitrile Butadiene Styrene (ABS) to Fuel Demand” is an in-depth report from GBI Research, which is focused on the demand side of the Asia Pacific b...	August 2012	$3500
Bolivia Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData Bolivia Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "Bolivia Silver Mining Market Overview and Forecast to 2020: Trends, Fis	August 2012	$1500
Indonesia Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData Indonesia Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "Indonesia Silver Mining Market Overview and Forecast to 2020: Trends,	August 2012	$1500
South Africa Coal Mining Market Overview and Forecast to 2020: Trends, Major Projects, and Competitive Landscape By GlobalData South Africa Coal Mining Market Overview and Forecast to 2020: Trends, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, "South Africa Coal Mining Market Overview and Forecast to 2020: Trends, Major Projec	August 2012	$1500
Peru Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape By GlobalData Peru Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Regime, Major Projects, and Competitive Landscape Summary GlobalData’s mining industry offering, ''Peru Silver Mining Market Overview and Forecast to 2020: Trends, Fiscal Re	August 2012	$1500
Oil & Gas Capital Expenditure Outlook, H1 2012 By GlobalData This is the latest report from industry analysis specialists, GlobalData, which provides a half-yearly review of the oil and gas sector’s capital expenditure outlook for 2012. The report provides a detailed analysis of the current and future...	August 2012	$3995
Life Insurance in Egypt, Key Trends and Opportunities to 2016 By Timetric SynopsisThe report provides in depth market analysis, information and insights into the Egyptian life insurance market, including:The Egyptian life insurance market’s growth prospects by life insurance cat...	August 2012	$1950
Social Media Market in Wealth Management By Timetric SynopsisThis report is a detailed study that explores the potential of Web 2.0Provides insight into social media practicesDetails the demographics of current social media usersExamines differen...	August 2012	$3800
Emerging Pharma Company Analysis: Onyx Pharmaceuticals By Datamonitor This analysis evaluates the company’s strategy and key strengths, weaknesses, opportunities and threats, and provides an overview of the company’s historical and forecast financial performance. The report also gives an in-depth analysi...	August 2012	$5700
The U.S. Steel Industry Outlook By SBI The steel industry is vital to the economic competitiveness of the United States. Steel serves as the backbone to automobiles, bridges, buildings, railroads, and machinery and is an important component of national defense weapons. Industry consoli...	August 2012	$4950
City Travel Briefing: Mumbai By Euromonitor International As India’s commercial centre and Bollywood capital, Mumbai remains a high profile destination for business and leisure visitors. Whilst the aftermath of the terrorist attacks in 2011 still overshadows the city’s appeal, further refurbishment of its a	August 2012	$2000
Tobacco: Eastern European Market Growth Stubbed Out by Soaring Russian Taxation By Euromonitor International Although the pricing strength of international brands has kept the market growing, the operating environment is increasingly tough as a series of tax and other legislative measures come into effect, particularly in Russia, the region’s dominant marke	August 2012	$2000
UK Private Medical Insurance 2012 By Datamonitor This report gives a comprehensive analysis of the UK private medical insurance sector. Three exclusive surveys provide insight into consumer trends and intermediaries attitudes towards private medical insurance. For the first time this report also...	August 2012	$3450
Global Handset Testing Market 2011-2015 By Infiniti Research TechNavio's analysts forecast the Global Handset Testing market to grow at a CAGR of 32.08 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing complexity of handsets. The Global Handse...	August 2012	$2000
Computer-aided Design Market in the APAC Region 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Computer-aided Design market in the APAC region to grow at a CAGR of 10.55 percent over the period 2011-2015. One of the key factors contributing to this market growth is increased outsourcing of product and engineer	August 2012	$1500
Data Center Equipment Market in India 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Data Center Equipment market in India to grow at a CAGR of 10.4 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in government cloud computing initiatives.	August 2012	$2000
Global Architectural Services Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global Architectural Services market to grow at a CAGR of 3.6 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing investment in the Global Construction indus	August 2012	$1500
Global Engineering Services Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global Engineering Services market to grow at a CAGR of 4.1 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing investment in the Global Construction industr	August 2012	$1500
Global Geographical Information System Market in the Natural Resource Industry 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global Geographical Information System market in the Natural Resource industry to grow at a CAGR of 9.3 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing d	August 2012	$1500
Global Green Data Center Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global Green Data Center market to grow at a CAGR of 34.06 percent over the period 2011-2015. One of the key factors contributing to this market growth is the innovative designs of data centers. The Global Green Data	August 2012	$1500
Global Micro Server Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global Micro Server market to grow at a CAGR of 69.48 percent over the period 2011-2015. One of the key factors contributing to this market growth is the growing need to reduce server space. The Global Micro Server m	August 2012	$1500
Global Patient Monitoring Systems Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global Patient Monitoring Systems market to grow at a CAGR of 6.04 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increased adoption of wireless patient monitoring	August 2012	$2000
Global Peripheral Vascular Devices Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global Peripheral Vascular Devices market to grow at a CAGR of 6.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing incidence of abdominal aortic aneurysm	August 2012	$2000
Global Product Data Management Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global Product Data Management market to grow at a CAGR of 10.93 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increasing need to reduce product development time.	August 2012	$1500
Global SaaS-based CRM Software Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Global SaaS-based CRM Software market to grow at a CAGR of 14.6 percent over the period 2011-2015. One of the key factors contributing to this market growth is the need for fast deployment. The Global SaaS-based CRM	August 2012	$1500
Global Ventilation Systems and Accessories Market 2011-2015 By Infiniti Research TechNavio''s analysts forecast the Gl

Home › August-2012

August-2012

TITLE PUBLISHED PRICE